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ABSTRACT
One area of research in the field of Autism Spectrum Disorders (ASDs) involves efforts
to better understand symptom manifestation at earlier points in an individual’s life. Researchers
have consistently emphasized the importance of early intervention for children with an ASD, but
the determination of the most efficacious treatment approach is often established on a case-bycase basis by taking into consideration an individual’s specific needs. The need for such
individualized treatment approaches is accentuated by the high prevalence of comorbid
psychopathology within the ASD population. The study of comorbid disorders among young
children with ASDs has been hindered by a lack of measures normed for an ASD population,
until recently. The development of the Baby and Infant Screen for Children with aUtIsm TraitsPart 2 (BISCUIT-Part 2) assessment battery has provided clinicians with an empirically derived
scale designed to assess comorbid psychopathology in young children with ASDs or atypical
development. The aim of the present study was to examine the diagnostic and temporal
influences on comorbid psychopathology symptoms in infants and toddlers with ASD.
Participants were separated into one of three groups based on their diagnoses (i.e., Autistic
Disorder [AD], Pervasive Developmental Disorder-Not Otherwise Specified [PDD-NOS], and
atypical development without an ASD). Children were assessed with the BISCUIT-Part 2 twice,
with the initial and follow up assessment occurring within one of two time intervals; 4 to 8
months, or 9 to 13 months. Results from the current study indicate that children diagnosed with
AD exhibit significantly less stable symptoms of comorbid psychopathology. Further, the time
between initial and follow up assessments is a significant factor influencing symptom
expression. Implications of these findings are discussed.
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INTRODUCTION
Autism Spectrum Disorders (ASDs) are a severe and lifelong set of neurodevelopmental
disorders (Rivet & Matson, 2011; Weinkauf, Zeug, Anderson, & Ala’i-Rosales, 2011). In
support of the neurodevelopmental origins, McPartland, Coffman, and Pelphrey (2011) have
presented research showing that irregular activity in the brain regions associated with social
interactions (i.e., mirror neurons) may act as a possible genetic marker for ASDs. The presence
of ASD is often recognized based upon abnormalities in three core areas: social interaction,
communication skills, and restricted and repetitive behaviors (Rivet & Matson, 2011; Weinkauf,
Zeug, Anderson, & Ala’i-Rosales, 2011; Xianchen, Hubbard, Fabes, & Adam, 2006). In addition
to these core symptoms, concomitant psychopathology and challenging behaviors are often
present (Bakken et al., 2010; Davis et al., 2011; Funabiki, Kawagishi, Uwatoko, Yoshimura, &
Murai, 2011; Horovitz et al., 2011).
Traditionally, diagnosticians have disregarded formulations of comorbid psychiatric
disorders for individuals with ASD (Lainhart, 1999). This diagnostic indifference has been
attributed to many factors. The unique manifestation of psychopathological symptoms when an
ASD is present makes differential diagnosis increasingly more difficult (Gillberg, 2010). Rutter
(1968) also highlighted the relative lack of agreed upon diagnostic criteria for an ASD diagnosis
as a contributing factor. However, due to the mounting evidence investigators have found
supporting the presence of co-occurring conditions and their subsequent impact (Bakken et al.,
2010; Gillberg, 2010; LoVullo & Matson, 2009; Matson & Minshawi, 2006; Matson & NebelSchwalm, 2007), the controversy regarding comorbid psychopathologies within ASDs has
largely been quelled. Challenging behaviors and psychopathology have consistently been
identified as occurring at high rates with ASD and are often targeted for intervention
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(Barthélémy et al., 1992; Dawson, Matson, & Cherry, 1998; Holden & Gitlesen, 2007; Matson &
Nebel-Schwalm, 2007; Paclawskyj, Matson, Bamburg, & Baglio 1997).
The addition of a comorbid psychiatric condition to individuals with an ASD diagnosis
necessitates the need for highly individualized interventions (LoVullo & Matson, 2009). For
example, while a behavioral intervention may be used to address symptoms of ASD, alternative
intervention techniques (e.g., psychotropic medication) may be necessary for some comorbid
disorders (LoVullo & Matson, 2009; Self, Hale, & Crumrine, 2010). Comorbid conditions can
often further complicate the diagnostic process and treatment plan, which often adversely affects
not only the individual, but those involved in the provision of care as well (Gray, Ansell, Baird,
& Parr 2011; Matson & Minshawi, 2007; Matson & Nebel-Schwalm, 2007).
While the need for early intervention has been recognized, there are currently few
existing comorbid psychopathology assessments normed for the ASD population. This dearth of
appropriate assessment tools contributes to the lack of understanding researchers, clinicians, and
parents have regarding co-occurring conditions in children with ASDs (Matson et al., 2010).
The use of traditional assessments (i.e., assessments used in the typically developing population)
to investigate and diagnose the presence of comorbid psychopathologies in individuals with
ASDs is insufficient due to the additive complexity in behavioral presentation (Matson et al.,
2007). Fortunately, the recent development of the Baby and Infant Screen for Children with
aUtIsm Traits-Part 2 (BISCUIT-Part 2) has provided an empirically validated assessment of
comorbid psychopathology in young children with ASD and atypical development (Matson,
Boisjoli, Hess, & Wilkins, 2011). In the current study the researcher utilized the BISCUIT-Part 2
to examine comorbid conditions in toddlers with and without an ASD by analyzing the
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diagnostic and temporal influences on symptom expression. Symptoms will be considered
“stable” if they do not differ significantly between the initial and follow up assessment periods.
Symptoms of psychopathology were assessed across two administrations of the
BISCUIT-Part 2. The same parents/caregivers of the infants and toddlers served as informants
each time as part of their participation in Louisiana’s EarlySteps Program. Symptom stability
was compared across participants falling into one of three diagnostic categories (i.e., Autistic
Disorder [AD], Pervasive Developmental Disorder – Not Otherwise Specified [PDD-NOS], and
atypically developing without an ASD) in order to determine if diagnosis significantly predicts
concomitant psychopathological expression. Additionally, temporal influences were examined
for each diagnostic category by inspecting the time interval between initial and follow up
assessment (i.e., 4 to 8 months, and 9 to 13 months). The history of ASDs, research on comorbid
psychopathology, and assessment techniques for this population are reviewed, followed by
details of the current study.
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HISTORY OF AUTISM SPECTRUM DISORDERS
In 1943, Leo Kanner published the seminal article “Autistic Disturbances of Affective
Contact.” He introduced a new type of developmental disorder, which is now commonly referred
to as autism. Kanner’s (1943) original article contained the descriptions of 11 children (i.e., eight
males and three females) ranging from 2 to 8 years of age. Each child presented with similar
symptomology which failed to explicitly meet any current diagnostic criteria. Though some
variation in appearance and severity was evident, the children all exhibited three core deficits,
discrepancies in language use and acquisition, insistence on sameness and stereotypic behavior,
and failure to relate to others and form proper social relationships. Van Krevelen (1971) and
Rutter (1978) later published research replicating these three core deficits, which were
popularized by Wing and Gould (1979) who referred to these deficits as the “autism triad.”
The term “autism,” itself, was not new to the field of psychology and was actually coined
in 1908, by Swiss psychiatrist, Eugene Bleuler (as cited in Fusar-Poli & Politi, 2008). Notably,
Bleuler did not introduce the term as nomenclature for a new neurodevelopmental disorder (as
cited in Fusar-Poli & Politi, 2008). Instead, he used the term to label, what he considered a core
feature of schizophrenia: “turning away from reality, sees life in fantastic pictures, and is
founded precisely upon autistic thinking.” (Bleuler, 1913, p. 874). Kanner, however, utilized the
term “autism” to specifically describe an individual’s inability to relate to themselves and others,
which he described as “extreme autistic aloneness” (Kanner, 1943, 1944). This overlap in
terminology created persistent diagnostic problems and turmoil amongst clinicians in the area of
differential diagnosis.
Kanner noted in his observations that clinicians most often described the children
expressing autism symptomology as being “feebleminded” or “schizophrenic.” The observed
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diagnostic overlap can be attributed to the childhood schizophrenia definition proposed by
Despert (1938), “ a disease process in which the loss of affective contact with reality is
coincident with or determined by the appearance of autistic thinking and accompanied by
specific phenomena of regression and dissociation.” (p. 366). Kanner, however, disagreed with
the diagnostic confusion and emphasized that “these characteristics form a unique syndrome, not
heretofore reported, which seems to be rare enough, yet is probably more frequent than is
indicated due to the paucity of observed cases” (Kanner, 1943, P. 242). In an attempt to
distinguish this new neurodevelopmental disorder from childhood schizophrenia, Kanner (1944)
proposed to rename it “early infantile autism.”
Kanner’s utilization of the term “autism” undoubtedly contributed to the general lack of
diagnostic differentiation, and consequently served as the topic of much discussion in the
literature of the period (Rutter, 1972a, 1978; Volkmar & Klin, 2005). During this period,
clinicians freely interchanged diagnoses of childhood schizophrenia, autism, and childhood
psychosis (Laufer & Gair, 1969; Rutter, 1978). Eisenburg (1966) noted the direct negative
impact that terminology confusion had on the ASD population and associated research, as many
clinicians and researchers struggled to distinguish autism and childhood schizophrenia (Matson
& Minshawi, 2006). The lack of differential diagnosis may be further attributed to the diagnostic
measures developed during this period which only sought to identify the presence of psychosis,
not a particular syndrome (Prior & Bence, 1975).
Similarly, early diagnostic manuals failed to differentiate ASD from childhood
schizophrenia. Childhood schizophrenia was the only official term available in the first and
second editions of the Diagnostic and Statistical Manual of Mental Disorders (American
Psychiatric Association [APA], 1952, 1968) to describe a child exhibiting the newly discovered
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autistic features. When AD first debuted in the World Health Organization’s (WHO)
International Classification of Diseases, 8th Revision (ICD-8; 1967), it appeared as “infantile
autism,” a sub-type of schizophrenia, and lacked any specified criteria. In the ICD-8 Glossary
and Guide, autism was classified under “behaviour disorders of childhood” (WHO, 1974). Later,
autism was later re-categorized as “psychoses with origin specific to childhood” within the ICD9 and subsequent Glossary and Guide (WHO, 1977, 1978).
The changing terminology was not without influence upon researchers. Diagnostic
confusion led some researchers to suggest terminology that pointed to potential causes of the
disorder. For example, Rutter and colleagues (1969) suggested the use of the provisional
terminology “disintegrative psychosis” to describe the period of profound regression in children
around the age of 4 that was considered distinct from both schizophrenia and infantile autism.
Van Krevelen (1971) sought to utilize the term “autismus infantum,” suggesting cerebral
disorders as the causal agent of infantile autism.
Diagnostic Development
Following Kanner and Asperger’s original works, research interests expanded
exponentially and created a divide amongst researchers. Some researchers sought to differentiate
ASDs from childhood schizophrenia, while others produced studies attempting to highlight their
similarities. Significant research contributions by Rutter (1968, 1972b, 1978), highlighted the
differences between autism and childhood schizophrenia. For example, Rutter (1978)
differentiated ASD from childhood schizophrenia by suggesting ASD had a 4:1 (male to female)
gender ratio, while suggesting the gender ratio in childhood schizophrenia is generally
recognized as being equal. Rutter (1972b, 1978) also showed that in direct contrast with
childhood schizophrenia symptoms, ASDs do not include hallucinations and delusions, but do
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include impaired intellectual function when compared to typically developing peers, stability of
presenting symptomology, and earlier onset. In conjunction with his efforts to distinguish ASDs
from childhood schizophrenia, Rutter and colleagues (1969) also sought to identify clear
diagnostic criteria to diagnose autism.
Two important distinctions would ultimately differentiate ASD and childhood
schizophrenia. The identification of a period of marked “regression” and the age criteria (i.e., 13)
identified by Despert (1938) in childhood schizophrenia directly contended with the clear and
evident deficit from birth seen in autism (Kanner, 1943; Rutter, 1978). However, in actuality, it
would be more than thirty years from the original observations before childhood schizophrenia
and autism were diagnostically distinguished (Volkmar, Klin, & Cohen, 1997). This feat only
occurred with the introduction of the “Pervasive Developmental Disorders” (PDDs) category,
which was included in the 1980 release of Diagnostic and Statistical Manual of Mental
Disorders, 3rd Edition (DSM-III; APA). The terms “PDD” and “ASD” are used interchangeably
in current research articles; however, the current paper will utilize only “ASD” henceforth
(Baird, Cass, & Slonims, 2003).
The ASD category is an umbrella term encompassing the varied degrees of
symptomology observed across the lifespan. Upon its introduction, ASD included five separate
disorders: infantile autism, residual infantile autism, childhood onset pervasive developmental
disorders, residual child-onset PDD, and atypical pervasive developmental disorder (Volkmar &
Klin, 2005). For the first time, the diagnostic criteria for each ASD presented in the DSM-III
were based on empirical research (Volkmar & Klin, 2005). DSM-III also employed a multi-axial
diagnostic approach, simultaneously accounting for symptom severity by identifying specific
criteria to correspond with each disorder (Matson & Minshawi, 2007; Volkmar & Klin, 2005).
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The introduction of ASDs in the DSM-III encouraged researchers to explore these
disorders further, and as data and knowledge grew, so did the discrepancies surrounding
diagnostic criteria. Based on supporting research, the APA sought to clarify the diagnostic
criteria along with other issues in the 1987 release of the Diagnostic and Statistical Manual of
Mental Disorders, 3rd edition-revised (DSM-III-R). The DSM-III-R reduced the number of ASD
diagnoses by completely removing infantile autism, residual infantile autism, and childhood
onset pervasive developmental disorders, replacing them with AD and PDD-NOS (Waterhouse,
Wing, Spitzer, & Siegel, 1989). A second significant change was the removal of the specified
age of onset for AD (i.e., onset prior to 30 months; Waterhouse et al., 1989). Waterhouse, Wing,
Spitzer, and Siegel (1989) also noted the additional establishment of diagnostic boundaries for
considering comorbid diagnoses.
Despite the progression and changes mentioned, it is notable that no version of the DSM
had yet sought to include the syndrome that Hans Asperger discovered. Only a year after
Kanner’s seminal 1943 article, Asperger wrote his thesis “Autistic Psychopathy in Childhood”
(Asperger & Frith, 1991). Written in German, Asperger’s thesis remained largely undiscovered
by the scientific community until it was eventually translated into English forty-seven years later
by Uta Frith. The thesis outlined the profiles of four children who expressed symptoms similar to
those seen in autism, but with a later age of onset, and “pedantric patterns of speech” (Asperger
& Frith, 1991). Asperger’s Syndrome (AS) did not appear in a diagnostic manual until its
inclusion in the International Classification of Diseases, 10th Edition (ICD-10), which was
released by the WHO in 1992. In addition to AS, the ICD-10 incorporated multiple ASDs;
atypical autism, disintegrative disorder, Rhett’s syndrome, and overactive disorder with mental
retardation and stereotypies (Rutter, 1989). Szatmari (1992) cited the overwhelming number of
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diverse clinical features and varied degrees of severity as reasoning to include such a large
number of diagnoses within the ASD umbrella. The diversified presentation of clinical features
within the autism spectrum was also acknowledged in the Diagnostic and Statistical Manual of
Mental Disorders, 4th Edition (DSM-IV; APA, 1994) and DSM-IV-Text Revision (DSM-IV-TR;
APA, 2000).
Presently, five disorders comprise the ASD category, AD, AS, Rhett’s Disorder,
Childhood Disintegrative Disorder, and PDD-NOS (APA, 1994, 2000; Lecavalier, Gadow,
DeVincent, Houts, & Edwards, 2009). In addition to categorical changes, the DSM-IV also
implemented criteria changes such as the reestablishment of an age of onset criteria for AD of 36
months (APA, 1994; Volkmar & Klin, 2005). To address the variance of symptom presentation,
the DSM-IV task force established separate criteria for each ASD category, with the exception of
PDD-NOS. The ASD diagnoses were arranged hierarchically so that AD required a minimum of
six criteria for diagnosis, and an AS diagnosis was considered only after AD was ruled out and
three criteria were met (Mandy, Charman, Gilmour, & Skuse, 2011). The PDD-NOS diagnosis
resides at the bottom of the hierarchal model, and was included to capture individuals that failed
to meet the specified criterion for a specific ASD, but still warranted an ASD diagnosis (e.g.,
sub-threshold symptoms, late onset; Mandy et al., 2011). The WHO (1992) collaborated with the
APA’s DSM-IV task force to ensure that the criteria they established would be in close alignment
with those set forth by their release of the ICD-10.
Although ASDs encompass five distinct disorders, the present study will only examine
AD and PDD-NOS due to limited data and insufficient diagnostic reliability within the toddler
age group for the latter three ASDs (i.e., AS, Childhood Disintegrative Disorder, and Rhett’s
Disorder; Lord, Luyster, Guthrie, & Pickles 2012; Matson, 2007; Matson et al., 2010; Matson,
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González, & Wilkins, 2009; Schopler, Reichler, Devellis, & Daly, 1980). Therefore, only AD
and PDD-NOS will constitute the ASD category when mentioned henceforth (Matson et al.,
2008; Worley, Matson, Mahan, Kozlowski, & Neal, 2011).
Differential Diagnosis
Defining and diagnosing ASDs has advanced considerably over time leading to a better
understanding of the presenting symptoms and features. However, Baird, Slonims, and Cass
(2003) suggested that differential diagnosis remains problematic due to the variance of
presenting symptomology along multiple dimensions, as implied by the ASD nomenclature. The
authors postulated that the variable presentation seen in ASDs is inherent and serves as a
hallmark of the disorders (Baird et al. 2003). Currently clinicians mainly consult two manuals in
the diagnosis of mental disorders, the DSM-IV-TR (APA, 2000), and the ICD-10 (WHO, 1992).
Volkmar and Klin (2005) demonstrated the similarity of the criteria levels between the two
respective manuals concerning the ASD categories. In a field trial of the DSM-IV conducted by
Klin, Lang, Cicchetti, and Volkmar (2000) examining the distinction between AD and non-PDD
diagnoses, the researchers observed an excellent inter-rater reliability (k = 0.95) across all raters
examined (i.e., experienced, inexperienced, psychologists, and psychiatrist). Due to the identified
similarity and the popularity of use surrounding the diagnosis of ASDs in the United States, the
present study will focus exclusively upon the DSM-IV-TR.
The DSM-IV-TR identifies the importance of differentiation within the ASD category, to
ensure the individual’s symptoms are not better accounted for by another ASD within the
spectrum (APA, 2000; Ghaziuddin & Mountain-Kimchi, 2004). Researchers have shown that
special considerations must be used when differentially diagnosing a younger population due to
an identified overlap of symptoms with several other early childhood disorders (e.g., general
developmental delays related to intellectual disability [ID] and severely delayed language; Baird
10

et al., 2003; Charman & Baird 2002; Lord, 1995; Van Daalen et al., 2009). As identified by
Willemsen-Swinkels and Buitelaar (2002), the importance of differential diagnosis transcends
the avoidance of misdiagnosis to include the identification of other imperatives such as
efficacious and ethical treatments, eligibility for services, rendering of appropriate services, and
prognosis. The difficulty of differential diagnosis is only exacerbated by the presence of cooccurring disorders which are frequently identified in ASDs (Baird et al., 2003; Gillberg &
Billstedt, 2000; Matson et al., 2010; Schreck, Williams, & Smith, 2004).
Autistic Disorder. Within the context of the five current developmental disorders of
ASD, AD includes criteria that most closely coincide with the symptomatology originally
documented in Kanner’s (1943) observations. A diagnosis of AD is made only if an individual is
exhibiting “markedly abnormal or impaired development” in each of the three principal symptom
domains as defined by the DSM-IV-TR: social interaction, communication, and a marked
restriction in interests or activities (APA, 2000, Cheng et al., 2009; Gutierrez et al., 2009;
Ketelaars et al., 2009; Lacroix et al., 2009; Matson & Sipes, 2010). The use of three distinct
categories of criteria for AD remained constant in the text revisions of both the DSM-III (APA,
1987), and DSM-IV (APA, 1994). Sevin, Knight, and Braud (2007) expressed that AD is the
most agreed upon and consistent disorder within the ASDs category.
Core symptoms expressed at 14 months in toddlers with AD remained relatively stable
when re-assessed at 36 months of age (Landa, Holman, & Garrett-Mayer, 2007). In related
research, Werner, Dawson, Munson, and Osterling (2005) reported that symptoms of AD
observed by parents between 3-6 months became more obvious deficits in social behavior at 12–
15 months of age. When the same children were re-assessed between the ages of 3 and 4, it was
found that the symptoms had persisted (Werner, Dawson, Munson, & Osterling, 2005). Matson
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and Horovitz (2010) suggested that identification of symptoms at earlier ages (i.e., 20 months)
was easier when symptoms were more severe (i.e., AD versus PDD-NOS).The diagnostic clarity
provided by the DSM-IV-TR (APA, 2000) likely contributes to the high stability observed in the
early diagnosis of AD (i.e., 24 months). The finding of high stability rates for early diagnosis has
been replicated across several studies (Charman et al., 2005; Cox et al. 1999; Lord 1995; Matson
et al., 2008; Moore & Goodson 2003; Worley et al., 2011).
To warrant a diagnosis of AD, an individual must present with two deficits
corresponding with impaired social interaction, at least one communication deficit, and at least
one behavior, interest, or activity presented in a stereotypic or repetitive nature (Taheri & Perry,
2012). Additionally, atypical or delayed functioning in at least one of three areas must be
observed prior to 36 months of age: “(1) social interaction, (2) language as used in social
communication, or (3) symbolic or imaginative play.” (APA, 2000, p.75; Buitelaar, Van der
Gaag, Klin, & Volkmar, 1999). A third and final criterion requires that the presenting features
not be more appropriately captured by either a diagnosis of Rhett’s Disorder, or Childhood
Disintegrative Disorder (APA, 2000; Wulffaert, van Berckelaer-Onnes, & Scholte, 2009).
Examples of the items provided for observable impairment of social interactions include but are
not limited to: a) gross impairment of multiple nonverbal behaviors (e.g., eye contact), b)
deficiency in emotional reciprocity, c) inability to acquire developmental or age appropriate
relationships, and d) retarded spontaneity in the sharing of social interests (APA, 2000; Buitelaar
et al., 1999; Hoffman, 2009; Taheri & Perry, 2012). Identified communication impairments
include a) a delayed or total absence of a developed spoken language, b) inability to initiate or
maintain conversations, c) the use of repetitive or stereotypic language, and d) the observed
absence of developmentally appropriate spontaneous play (APA, 2000; Buitelaar et al., 1999). At
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least one repetitive and stereotypic behavior, interest, or activity pattern must also be present,
such symptoms include a) an abnormal focus or intense preoccupation with at least one
stereotypic or repetitive interest pattern, b) insistence of adherence to fixed, nonfunctional rituals
or routines, and d) a fixation with object components (APA, 2000; Buitelaar et al., 1999; Taheri
& Perry, 2012).
Utilizing the criterion outlined above, Fombonne (2005) estimated a prevalence rate of
AD diagnosis at 13 per 10,000. Reviews of the criterion proposed to appear in the Diagnostic
and Statistical Manual of Mental Disorders, 5th Edition (DSM-5; proposed for publication in
2013) has indicated a combination of the impaired social interaction domain with the
communication deficit domain into a singular impaired social/communicative behaviors category
(APA, 2010; Kuenssberg, McKenzie, & Jones, 2011). This combination of criteria is a source of
controversy, as some researchers claim that such changes will greatly reduce ASD prevalence
rates (Matson et al., 2012; Taheri & Perry, 2012).
Pervasive Developmental Disorder – Not Otherwise Specified. In the absence of the
specified criterion, a more sweeping parameter is provided by the DSM-IV-TR for the diagnosis
of PDD-NOS and reads as follows: ‘‘should be used when there is a severe and pervasive
impairment in the development of reciprocal social interaction associated with impairment in
either verbal and nonverbal communication skills, or with the presence of stereotyped behavior,
interests, and activities’’ (APA 2000, p.84). Additionally, a PDD-NOS diagnosis should only be
given if the presenting symptoms are not better accounted for by other diagnoses (i.e.,
developmental disorder, schizophrenia, schizotypal personality disorder, or avoidant personality
disorder; APA, 2000; Buitelaar et al., 1999; Karabekiroğlu & Akbaş, 2011).
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A PDD-NOS diagnosis is often made in light of the atypical or sub threshold presentation
of symptoms, or the failure to meet the age of onset criterion (Buitelaar et al., 1999). The PDDNOS diagnosis is situated at the base of the hierarchical arrangement of ASDs as provided by the
DSM-IV-TR (APA, 2000; Karabekiroğlu & Akbaş, 2011). Researchers have shown that
clinicians often assign a PDD-NOS diagnosis when impairment is observed, but the child’s
presentation fails to meet the criterion for another diagnosis on the spectrum (APA, 2000;
Buitelaar et al., 1999; Lord & Risi, 1998; Matson & Boisjoli, 2007; Tidmarsh & Volkmar, 2003).
The PDD-NOS category and especially early diagnosis is a point of much contention.
Towbin (2005) mentioned specific concern surrounding the ambiguity of the current criteria and
current diagnostic utilization of PDD-NOS. A recent meta-analysis investigating the stability of a
PDD-NOS diagnosis utilizing the DSM-IV-TR criterion further highlighted researchers’
concerns. Rondeau and colleagues (2011) investigated the findings of eight longitudinal studies,
which included a diagnosis made prior to 36 months of age and found that only 35% of those
individuals initially diagnosed retained the PDD-NOS diagnosis at a subsequent 3-year followup. Stone and colleagues (1999) followed 65 children who received an initial AD or PDD-NOS
diagnosis at age 2. When the same children were subsequently re-evaluated at age 3, a greater
diagnostic instability (i.e., no diagnosis, or change to AD diagnosis) was observed in those with
PDD-NOS than in children who were diagnosed with AD (Stone et al., 1999). Similarly, Worley,
Matson, Mahan, Kozlowski, and Neal (2011) examined the stability of early diagnosis in 114
toddlers and reported that 15.8% of toddler’s diagnoses changed from either PDD-NOS to
atypical development or vice versa.
The indistinct nature of the criteria provided for PDD-NOS has been suggested as a
contributing factor to the difficulty of discerning PDD-NOS from atypical development
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(Buitelaar et al., 1999; Chawarska, Klin, Paul, & Volkmar, 2007; Nebel-Schwalm & Matson,
2008; Tidmarsh & Volkmar, 2003). Stone and colleagues (1999) suggested that the greater
stability observed in AD when compared to PDD-NOS may be reflective of “a more coherent or
well-defined symptom cluster” (p. 224). The authors further suggested that the stability of AD is
bolstered by the severity of symptoms required for diagnosis (Stone et al., 1999). In addition to
relatively vague criteria, other concerns have been voiced. Siegel (1991) expressed the concern
that depending on the age at which they are assessed, some deficits may not yet be clearly
evident or applicable (e.g., the children may not have peer friends, or the opportunity to develop
atypical speech patterns).
In a recent study of PDD-NOS using DSM-IV-TR criteria, Fombonne (2005) identified an
incidence rate of 20.8 per 10,000. Consequently, the incidence for PDD-NOS is higher than
either AD or AS. Despite the observed increase in prevalence rate, PDD-NOS is identified as
being studied significantly less than any other ASD (Chakrabarti & Fombonne, 2005; Matson &
Boisjoli, 2007). Recent reviews of the proposed changes in DSM-5 have reported that the
changes in criteria will increase diagnostic sensitivity and specificity. Huerta, Bishop, Duncan,
Hus, and Lord, (2012) reported that the DSM-5 is working to create a single diagnostic category
of autism spectrum disorder (ASD). Under the proposed changes, the current three-domain
model will be replaced by a two-domain model, the age of onset criteria will be relaxed, and
additional criteria will include symptoms not previously included in DSM-IV-TR (e.g., sensory
interests and aversions; Huerta et al., 2012).
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COMORBID PSYCHOPATHOLOGY IN ASD
De Graaf, Bijl, Smith, Vollebergy, and Spijker, (2002) described the comorbidity of
psychiatric disorders as “the presence, simultaneously or in sequence, of two or more disorders
in a person within a certain period of time.” Researchers are in agreement that “pure” disorders
are relatively infrequent and that most cases involve a client meeting criteria for two or more
disorders simultaneously (Goldstein, Lopez, & Puente, 2011). Within the context of the current
paper, the term “comorbid” refers to the presence of an ASD and one or more concurrent
psychiatric disorders.
Since the initial documentation of children with an ASD, behaviors other than the core
symptoms were observed, such as inattentiveness, food selectivity, tantrums, and abnormal
attention to detail (Brereton, Tonge, & Einfeld, 2006; Kanner, 1943; LoVullo & Matson, 2012).
In comparison to research investigating comorbid psychopathology in other disorders, Matson
and Nebel-Schwalm (2007) suggested that the same research in the ASD population is relatively
absent. In addition to a general deficit of researchers investigating comorbid psychopathology in
the ASD population, Angold and Egger (2004) reported that such studies are extremely rare in
young children. Researchers have expressed that the variation in presentation of some disorders
may be more easily identified as distinct from an ASD (e.g., depression), while others are in-line
with ASD symptomology (e.g., obsessive-compulsive disorder; Matson & Nebel-Schwalm,
2007). Given this information, Matson and Nebel-Schwalm (2007) suggested a cautionary
approach to the diagnosis of comorbid psychopathology.
Current Conceptualization
Until recently researchers expressed disagreement concerning the presence of comorbid
psychopathology, and the validity of comorbid diagnoses in ASDs. The American Academy of
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Child and Adolescent Psychiatry (1999) suggested that the presence of emotional problems and
challenging behaviors within the ASD population may not warrant additional diagnosis, instead
being better expressed as symptom clusters related to ASD. Hess, Matson, and Dixon (2010)
indicated that much of the disagreement surrounding comorbid diagnosis has stemmed from a
dearth of assessments available for the identification of comorbid disorders. While measures of
comorbid psychopathology are relatively common for the general population, few are normed for
an ASD population (Matson et al., 2010). The variation of both severity and functional abilities
within the ASD population impacts the presentation of psychiatric symptoms, thus increasing the
difficulty of accurate assessment and subsequent differential diagnosis (Gillberg & Billstedt,
2000; Matson & Rivet, 2008; Tsai, 1996).
Researchers targeting children with ASDs have consistently replicated results showing
higher occurrence rates of comorbid disorders when compared to their typically developing peers
(Gillberg & Billstedt, 2000; Kim, Szatmari, Bryson, Streiner, & Wilson, 2000; Schreck et al.,
2004). For ASD, estimates of the psychiatric comorbidity rate have ranged from 35% (Morgan,
Roy, & Chance, 2003) to 70% (Simonoff et al., 2008). A review of current literature reveals
multiple studies highlighting the symptomology overlap between ASDs and comorbid disorders
(Attention-Deficit/Hyperactivity Disorder; ADHD), as well as psychiatric symptoms such as
depression or anxiety (Ghaziuddin, Ghaziuddin, & Greden,, 2002; Hallett, Ronald, & Happe,
2009; Simonoff et al., 2008). Despite the growing interest in comorbid psychopathology in
ASD, much of the research is limited to older children, adolescents, and adults. Matson and
colleagues (2010) recognized the sparse knowledge of comorbid psychopathology symptoms
within the infantile ASD population, while citing the lack of valid assessments as the
contributing factor.
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The observed high prevalence rate of comorbid symptoms has been suggested to be
further influenced by the presence of another disorder found to commonly co-occur with ASD,
intellectual disability (Matson & Shoemaker, 2009). Researchers have shown that 50-75% of the
ASD population also meet criteria for a concurrent diagnosis of intellectual disability (Matson &
Shoemaker, 2009; Rutter & Schopler, 1987; Wing, 1981; Wing & Gould 1979). The overlap
between ASD and intellectual disability is critical as both populations are associated with
increased risk for comorbid disorders (Borthwick-Duffy & Eyman, 1990; Bregman, 1991;
LoVullo & Matson, 2009; Matson & Shoemaker, 2009). Trillingsgaard, Sørensen, Nemec, and
Jørgensen (2005) identified that the difficulty of early ASD diagnosis is compounded by the high
co-occurrence of intellectual disability and the symptomology overlap with other developmental
disorders (e.g., impaired communication and social interaction). Attempts to identify additional
markers that may aid in the differentiation of developmental disorders have not been fruitful.
Researchers attempting to identify factors such as age, sex, or intelligence quotient as significant
predisposing factors for developing a comorbid disorder in children with ASD have been
unsuccessful (Brereton et al., 2006; Worley & Matson, 2011).
The development of interventions for ASD has advanced despite the remaining difficulty
of diagnostic differentiation. While no identified treatment is unanimously considered the most
effective intervention for ASDs, there has been a steady increase in the popularity and perceived
benefit of early intervention for ASDs (Hwang, Hughes, 2002; Rogers, 1996; Tanguay, 2000). A
growing body of research has linked the early identification and diagnosis of ASDs and
comorbid psychopathologies with increased rates of success surrounding the implementation of
early intensive intervention programs (Ben-Itzchak, Lahat, Burgin, & Zachor, 2008; Eaves &
Ho, 2004; Matson & Smith, 2008; McEachin, Smith, & Lovaas, 1993). Specifically, the use of
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early intensive behavioral intervention (EIBI) for the improvement of various functioning
domains within toddlers with ASD has been suggested (Granpeesheh, Tarbox, & Dixon, 2009;
Reichow, 2012; Worley et al., 2011).
EIBI has been touted as critical for the improvement of an individuals’ long-term
prognosis following replication in multiple studies (Lord, 1995; Matson & Smith, 2008; Mays &
Gillon, 1993; Prizant & Wetherby, 1988; Reichow, 2012). In an initial study investigating the
impact of EIBI, Lovaas (1987) reported a success rate of 47% for those children who received
EIBI (i.e., intelligence quotient >85 and unassisted placement in a general education setting).
Since Lovaas’s (1987) exploratory study, a growing body of research supporting EIBI’s efficacy
has accumulated. In a review of five separate meta-analyses investigating the efficacy of EIBI,
Reichow (2012) found that on average, the effects produced were strong and robust. However,
the research also highlighted the fact that no treatment to date has been effective for every child
with ASD (Reichow, 2012). The variance seen in treatment effectiveness can no doubt be
attributed to a multitude of factors. Wallace and Rogers (2010) identified the individualization of
treatment as a key factor in the development of effective interventions. Additionally, the
presence of comorbid psychopathological conditions has been identified as a significant factor
that would necessitate an individualized treatment regimen (Bakken et al., 2010; Gillberg, 2010;
LoVullo & Matson, 2009).
Despite such emphasis and interest in early intervention, there has been little research
attempting to advance our understanding of ASDs and comorbid psychopathology symptom
manifestation in infants (DeGiacomo & Fombonne, 1998; Howlin & Moore, 1997; Matson et al.,
2010; Siperstein & Volkmar, 2004). The importance of the early and accurate identification of
comorbid psychopathologies and ASDs is inherent if early intervention programs are to be
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successful ventures (Hess, Matson, & Dixon, 2010). The necessity of accurate diagnosis
becomes especially important when comorbid disorders are present, as this often creates a need
for highly specialized intervention centered upon the individual’s unique presentation (Joshi et
al., 2010). Researchers have highlighted the necessity of identifying psychopathologies in
children with ASDs based upon the perceived benefits of the multiple treatment options available
to include: educational, pharmacological, social interventions, and psychological treatments
(Birmaher, Quintana, & Greenville, 1988; Ghaziuddin, 2002; Howlin, 1998).
Common Comorbid Symptoms in ASD
Researchers examining comorbid psychopathology in children with ASD have shown
increased occurrence rates of both internal and external symptoms associated with multiple
psychopathological disorders (e.g., ADHD, anxiety disorder, conduct disorder; Hallett, Ronald,
& Happe, 2009; Hayashida, Anderson, Paparella, Freeman, & Forness, 2010; Simonoff et al.,
2008; Skuse et al., 2009). The increased occurrence of anxiety symptoms in ASD populations in
comparison to both typically and atypically developing populations is well founded (Farrugia &
Hudson, 2006; Kim, Szatmari, Bryson, Streiner, & Wilson, 2000; Russell & Sofronoff, 2005).
Evans, Canavera, Kleinpetere, Maccubbin, and Taga (2005) determined that children with ASDs
exhibit significantly higher levels of fears and phobias than those with Down syndrome (DS),
mental age peers, and chronological peers. The researchers also identified a positive correlation
between the presence of fears and phobias and increased hyperactivity, impulsivity, and conduct
behaviors in children with ASD (Evans, Canavera, Kleinpetere, Maccubbin, & Taga, 2005).
Muris, Steerneman, Merckelbach, Holdrinet, and Meesters (1998) expressed the importance of
identifying and treating anxiety symptoms due to the impairment of daily functioning and
distress these symptoms cause. While researching anxiety symptoms in children with ASD,
Chang, Quan, and Wood (2012) observed a strong positive correlation between level of social
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functioning impairment, and the severity of symptoms commonly associated with social anxiety
disorder. Matson, Mahan, Sipes, and Kozlowski (2010) suggested that the extreme variation in
comorbid symptoms can be generally combined into five major categories: tantrum/conduct
behavior, inattention/impulsivity, anxiety/repetitive behavior, avoidance behavior, and
eating/sleeping problems.
Tantrum/Conduct Behavior. The comorbid incidence of tantrum and conduct behaviors
within the ASD population is acknowledged as a contributing factor associated with a poor
prognosis due to its hindrance of intervention strategies (Matson et al., 2010). Researchers
comparing rates of conduct behavior in typically developing individuals and those with an ASD
have identified significantly higher rates of aggression and tantrum behaviors within the ASD
population (Horner, Carr, Strain, Todd, & Reed, 2002). Dominick, Davis, Lainhart, TagerFlusberg, and Folstein (2006) reported that 70% of the children with autism included in their
study had experienced severe tantrums. Additionally, the authors reported that onset of tantrums
occurred before 3 years of age in half of the participants. Elsewhere, researchers have found
tantrum behaviors to occur more frequently in children with ASD than their peers diagnosed with
intellectual disability (Ando & Yoshimura, 1979). Utilizing the BISCUIT-Part 3 Matson and
colleagues (2010) observed an increase in the endorsement for all challenging behaviors (e.g.,
Aggressive and Destructive Behavior, Stereotypies, and SIB) when symptoms of comorbid
psychopathology were also present. Robb (2010) suggested that symptoms linked to irritability
such as temper tantrums and aggression are major predisposing factors leading to problems in
multiple environments (e.g., school, home), and that these behaviors often result in referrals for
evaluation and treatment.
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Conduct disorder and challenging behaviors have been identified as behavior which
violates societal norms or the basic rights of others, or are a grave violation of established rules
such as aggression, property destruction, and theft (APA, 2000; Essau & AnastassiouHadjicharalambous, 2011; Lahey & Waldman, 2012; Singh, Lancioni, Winton, & Singh, 2011).
Tantrums are often identified as challenging behaviors that encompass a wide-ranging
continuum of severity and form. Daniels, Mandleco, and Luthy (2012) defined temper tantrums
as extreme and episodic frustration or anger. Tantrum behaviors often include screaming, crying,
hitting, and throwing items (Davidson, 2006; Potegal & Davidson, 2003). Matson and Neal
(2009) identified aggression, non-adherence, property destruction, and self-injury as challenging
behaviors commonly observed in individuals with ASD. These behaviors often become a clear
deviation from the norm when the child first enters a scholastic setting (Pringle, Colpe,
Blumberg, Avila, & Kogan, 2012). This context allows for the direct comparison to peers,
highlighting the differentiation and is often the reasoning for treatment referrals, and subsequent
screening (Wiggins, Baio, & Rice, 2006). Prior to any diagnosis, it is important to differentiate
the hypothesized cause surrounding the presentation of tantrum and conduct behaviors (Didden
et al., 2012). For example, behaviors such as head banging could be elicited due to the
experienced discomfort stemming from an undiagnosed medical condition, instead of an ASD.
Similarly, in a study examining the presentation of conduct behavior, Evans and colleagues
(2005) found a strong positive correlation between the presence of fears and phobias and conduct
behaviors.
Inattention/Impulsivity. Several studies have revealed that in comparison to their
typically developing peers, children diagnosed with ASDs exhibit symptoms associated with
Attention-Deficit/Hyperactivity Disorder (ADHD) at a much higher rate (Brereton et al., 2006;
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Kim et al., 2000; Lee & Ousley 2006; Leyfer et al., 2006; Simonoff et al., 2008). Lee and Ousley
(2006) identified significantly higher hyperactivity-impulsivity scores in children and
adolescents with autism than their peers regardless of ASD type. The presence of ADHD is
commonly associated with impaired social and communication skills, both of which are
symptoms commonly seen in children with ASDs (Holden & Gitlesen, 2006; Matson & Wilkins,
2008; McConaughy, Volpe, Antshel, Gordon, & Eiraldi, 2011; Schreck &Williams, 2006; Selfe,
2002; Sibley, Evans, & Serpell, 2010). Despite supportive research, a comorbid diagnosis of
ADHD when an ASD is present is currently prohibited by the DSM-IV-TR (APA, 2000; Willcutt
et al., 2012). Regardless, intervention remains crucial due to the observed impairment of
individuals interactions in multiple settings (e.g., home and school) associated with symptoms of
hyperactivity and impulsivity (Loveland & Tunali-Kotoski, 2005).
Willcutt and colleagues (2012) identified three different diagnoses associated with
inattention and impulsivity; ADHD, predominantly inattentive type, ADHD, predominantly
hyperactive-impulsive type, and ADHD, combined type. In order to meet criteria for any of the
above ADHD types, a child must present with symptoms that are considered to be maladaptive
and different from their peers for a period of at least six months (Willcutt et al., 2012). This
qualifier is also accompanied by an age criterion indicating that some impairment be present
prior to the child’s seventh birthday (APA, 2000; Sibley et al., 2012, Willcutt et al., 2012).
Additional criteria requires that the behaviors occur in more than one setting (e.g., at home and at
school), cause clinically significant impairment in social, academic, or occupational functioning,
and they must not occur in-conjunction with a psychotic disorder (e.g., Schizophrenia), or be
better accounted for by another mental disorder (e.g., mood disorder, anxiety disorder; APA,
2000; Sibley et al., 2012).
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Avoidance Behavior. The active avoidance of social situations, events, or places, is a
broad description of the behavior commonly observed within the ASD population. Schleismann
and Gillis (2011) identified that avoidance behaviors in children with ASD can be both physical
(e.g., hiding, running away) and verbal (e.g., negative verbalizations). Escape behaviors such as
the examples given above impede both intervention and caregiving. Similarly, escape maintained
behaviors driven by the social aversion commonly witnessed in the ASD population negatively
impact the areas of education, and employment (Kemp & Carr 1995; Moore, Yufang, McGrath,
& Powell, 2005; Reese, Richman, Belmont, & Morse, 2005).
Multiple factors have been identified as influencing avoidant behaviors. One
comparative analysis suggested that disruptive/avoidant behaviors by individuals with an ASD
are maintained by factors of both attention and escape (Reese, Richman, Belmont, & Morse,
2005). When discussing their results, the authors postulated that gender may operate as an
influencing factor upon behavior function (Reese et al., 2005). Matson and Hess (2010) found
that when compared to a PDD-NOS and a control group, children with AD evinced significantly
greater avoidance behaviors. The increased prevalence of avoidant behaviors in children with
ASD is compounded by an observed increase in the severity of these behaviors. Utilizing the
BISCUIT-Part 2 to assess the severity of avoidance behavior in a sample of 309 infants and
toddlers with an ASD diagnosis, Matson, Boisjoli, and Wilkins (2007) found 8.7% exhibiting
moderate impairment and 6.1% exhibiting severe impairment. The presence of avoidance
behaviors has also been linked to the presence of other comorbid symptoms. Schleismann and
Gillis (2011) found an increase in avoidance behaviors when both ASD and symptoms of an
anxiety disorder were present. Other researchers have found that when compared to both
typically developing and developmentally delayed peers, children with ASDs experience
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increased rates of fears and phobias. These researchers postulated that the elevated experience of
fear and phobias may be directly related to the presentation of avoidance behaviors (Evans,
Canavera, Kleinpeter, Maccubbin, & Taga, 2005; Matson & Love, 1990).
Anxiety/Repetitive Behavior. The presence of restricted and repetitive behaviors has
been consistently recognized across the development and evolution of the ASD category. Kanner
(1943) described the behaviors he observed as repetitious, high in frequency, and seemingly
oriented towards preservation of environment. Despite being a core symptom in ASDs, Lewis
and Bodfish (1998) acknowledged the relative lack of research being conducted on restricted and
repetitive behaviors. Bodfish, Symons, Parker, and Lewis (2000) hypothesized that the relative
ambiguity of terminology being utilized as descriptors for restricted and repetitive behaviors has
acted as a source of hindrance upon further development and advancement within the area. The
present categorization of restricted and repetitive behaviors provided by the DSM-IV-TR has
been identified as being a source of further hindrance upon the research due to the broad range of
behaviors it encompasses. To address this broad range of behaviors, multiple researchers have
proposed a mixed categorization approach (Bodfish et al., 2000; Cuccaro et al., 2003;
Papageorgiou, Georgiades, & Mayreas, 2008; Szatmari et al., 2006). Such a mixed categorization
has been suggested to be implemented in a mock hierarchical fashion in an effort to distinguish
between what researchers identified as “high order” behaviors (i.e., compulsive/impulsive
behaviors) and “low-order” behaviors (e.g., repetitive speech, and sensory/motor behaviors;
Cuccaro et al,.2003; Szatmari et al., 2006).
Hand flapping, body rocking, and the repetitive use of words or phrases are examples of
observed stereotypies in children with ASDs (O’Reilly et al., 2010). These challenging behaviors
often become identified as priorities for treatment due to the negative impact they have on the
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individual’s social encounters (Lam & Aman, 2007), familial life (Gordon, 2000), and education
(Sigafoos, Arthur, & O’Reilly, 2003; Varni, Lovaas, Koegel, & Everett, 1979).When compared
to other atypically developing populations, there is an significant increase in the prevalence of
stereotypic restricted and repetitive behaviors within the ASD population (Green et al., 2006;
Lord & Pickles, 1996; Szatmari, Bartolucci, & Bremner, 1989; Turner, 1999). Researchers have
expressed the importance of investigating symptoms of restricted and repetitive behaviors due to
the negative impact they have upon a child’s prognosis due to their inherent complication of their
behavioral repertoire and social stigmatization (Howlin, 1998; Howlin & Moss, 2012).
The presence of anxious behavior has been observed continuously since the original
discovery of ASD. Kanner (1943) described it as “anxiously obsessive desire for the
maintenance of sameness.” (p.245). Of the ten different anxiety disorders recognized by the
DSM-IV-TR (APA, 2000), researchers highlight the common occurrence of symptoms associated
with panic disorders, obsessive-compulsive disorder, and social anxiety disorder within the ASD
population (Tantum, 2000). Research by Gillott, Furniss, and Walter (2001), highlighted specific
endorsement increases on the subscales of symptoms associated with separation anxiety and
obsessive-compulsive disorder when an ASD was present. The presence of anxiety symptoms
has also been linked to the individual’s level of intellectual functioning. Adults with high
functioning autism have been identified as exhibiting rates of co-morbid obsessive-compulsive
disorder as high as 25% based upon ICD-10 criteria (Russell, Mataix-Cols, Anson, & Murphy,
2005). The influence of these comorbid symptoms transcends their immediate impact and has
been shown to influence other behaviors. For example, the presence of repetitive behaviors and
anxiety has been shown to have a strong correlation with increased levels of aggressive and
destructive behaviors (Matson, Mahan, Sipes, & Kozlowski, 2010).
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Eating Problems. Among the eating disorders defined by the DSM-IV-TR, the current
study will focus only upon symptoms associated with three due to their elevated co-occurrence in
ASDs. Symptoms of Pica, rumination, and feeding disorder of infancy or early childhood have
all been observed at increased rates in individuals with ASD (Matson, Hattier, & Turygin, 2012;
Råstam, 2008). A diagnosis of pica is centered upon the appetite for and purposeful ingestion of
non-nutritive substances (Matson et al., 2012; Tewari et al., 1995). Due to the potential
influences of cultural beliefs, chemical imbalances, and social skills, researchers caution that a
formal diagnosis should only be ascribed after the investigation of extraneous influences (Matson
et al., 2012; Seiverling, Williams, & Sturmey, 2010). Rumination involves the regurgitation of
food after a meal with the intent of re-experiencing the previously eaten items. Involuntary
occurrences due to gastrointestinal illness or a presenting medical condition must be ruled out
before an individual may be diagnosed with rumination (Darling, Otto, & Buckner, 2011; Lang
et al., 2011; Råstam, 2008). The diagnosis of a feeding disorder during infancy or early
childhood occurs specifically before six years of age and involves the failure to consume enough
food across no less than one month to allow for normal growth and weight gain (Chatoor, 2002;
Bruns & Thompson, 2010). In addition to symptoms associated with the above disorders,
children with ASDs often exhibit behaviors that inhibit or complicate meal consumption.
However, these behaviors are not diagnosable disorders, such as food selectivity (e.g.,
temperature, texture, liquid avoidance, and color), or food refusal (Seiverling, Williams, &
Sturmey, 2010).
Across time, a trend of increasing eating and sleeping complications has been
documented within the ASD population (Kanner, 1943; Richdale, 1999; Shreck et al., 2004).
Pooni, Ninteman, Bryant-Waugh, Nicholls, and Mandy (2012) failed to find a significant
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correlation between a group of children diagnosed with an ASD and early onset eating disorder
when compared to their typically developing peers. However, the researchers observed that those
with an early onset eating disorder consistently expressed elevated levels of ASD traits. Williams
and Seiverling (2010) showed that of the available data and reports on feeding problems, food
selectivity was the most prevalent in children with ASDs. An examination of feeding program
referrals, found that 46% of children with an ASD diagnosis presented with symptoms of food
selectivity (Bowers, 2002). While researchers have investigated the presence of eating disorders
in children and adults, there is only minimal research investigating occurrence in an infantile
ASD population. While commenting on the paucity of research of eating disorders in infants
with ASDs, Pooni and colleagues (2012) urged the use of caution in attempting to supplement
the knowledge gap with generalized research from an adult population.
Sleeping Problems. Another comorbid disturbance afflicting the ASD population
involves sleep. Currently researchers suggest that younger children with ASD most often
experience symptoms associated with bedtime resistance, sleep anxiety, parasomnias, and night
waking’s (Goldman, 2012; Park et al., 2012; Xianchen et al., 2006). In direct agreement with this
finding, researchers analyzing parental reports have shown that the rates of reported sleep
problems in individuals with an ASD (50%-80%) is significantly more prevalent then
comparison group rates (9% to 50%; Allik, Larsson, & Smedje, 2006; Couturier, et al., 2005;
Malow et al., 2006; Polimeni, Richdale, & Fancis, 2005; Xianchen et al., 2006). Richdale (2001)
suggested that two-thirds of children in the ASD population will experience a sleep problem.
Gillberg and Coleman (1992) proposed the autistic population is one in which etiology
varies tremendously based upon a multitude of factors (e.g., genetic, metabolic, and
physiological influences). Researchers have highlighted multiple factors influencing sleep
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disturbances. The presence of a sleep problem has been shown to correlate with the presence of
other comorbid psychopathology symptoms, such as: internalizing and externalizing problems,
aggression, somatization problems, and withdrawal (Park et al., 2012; Xianchen et al., 2006).
Additionaly, Park and colleagues (2012) identified the significant influence of child-rearing on
sleep behaviors. The authors exemplified the factorial influence by identifying an elevated risk of
major depression when symptoms of depression (e.g., sleep and appetite disturbance) are
combined with the presences of histrionic familial affective disorders. Sleep disturbances have
been demonstrated to not only affect the child themselves negatively, but researchers have
suggested that the influence also impacts parental quality of life (Lam, Hiscock, & Wake, 2003;
Meltzer & Mindell, 2007).)
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COMORBID PSYCHOPATHOLOGY IN NON-ASD
ASDs aside, other developmental disorders are included within the DSM-IV-TR, a
number of which are also positively correlated with increased rates of comorbid
psychopathology. When compared to their typically developing peers, children with atypical
development without an ASD also encounter increased rates of comorbid psychopathology
(Matson, Fodstad, Mahan, & Sevin, 2009; Tervo, 2007) and challenging behaviors (Baker,
Blacher, Crnic, & Edelbrock, 2002; Dixon, Kurtz, & Chin, 2008; Matson, Neal, Fodstad, &
Hess, 2010; Murphy et al., 2005).
Egger and Angold (2006) identified five groups of psychiatric disorders that are
commonly found in atypically developing children: ADHD, oppositional defiant and conduct
disorders, anxiety disorders, and depressive disorders. Deficiencies in communication and motor
skills have similarly been identified (Matson, Mahan, Kozlowski, & Shoemaker, 2010). Of great
importance is the fact that these impairments are not isolated incidents linked to a singular
disability and have been identified in children with a variety of developmental diagnoses such as;
intellectual disability, premature birth, epilepsy, Down Syndrome, and seizure disorder (APA,
2002; Coe et al., 1999; Perry, Flanagan, Geier, & Freeman, 2009; Ghaziuddin, Tsai, &
Ghaziuddin, 1992; Matson et al., 2010; Oliver & Buckley, 1994; Stephenson & Dowrick, 2005).
Matson, Mahan, Kozlowski, and Shoemaker (2010) found that in general, when the ASD
population was compared with other diagnoses within the atypically developing population, the
latter generally reached each developmental milestone earlier than individuals with an ASD.
While the occurrence of comorbid psychopathology and challenging behaviors is exhibited by
the atypically developing population, recently researchers have shown that the frequency is
significantly less than rates seen in those where an ASD is present (Davis et al., 2010; Matson et
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al., 2010). However, in order for proper intervention and services to be rendered, the early
identification and proper diagnosis remains paramount regardless of diagnosis or prevalence rate.
Common Comorbid Symptoms in non-ASD
Researchers investigating the atypically developing population indicate that the
individual’s primary diagnosis may serve as a predisposing factor for the development of
concomitant psychopathology. For instance, when compared to peers without Cerebral Palsy,
children with Cerebral Palsy were found to exhibit increased rates of symptoms associated with
hyperactivity, conduct, and emotional problems (Parkes & McCusker, 2008). Comorbid
symptoms such as ADHD, or conduct problems have been frequently observed in those
diagnosed with Down syndrome (Myers & Pueschel, 1991; Roizen & Patterson, 2003). Within
the intellectually disabled population, researchers have commonly observed symptoms of
depression, anxiety disorders, and ADHD (Deb, Thomas, & Bright, 2001; Dekker & Koot, 2003;
Hastings, Beck, Daley, & Hill 2005). Of those diagnosed with a Tic Disorder studies have shown
that between 35-50% exhibit symptoms sufficient to meet diagnostic criterion for ADHD
(Freeman, 2007; Kurlan et al., 2002; Wang & Kuo, 2003). Further, Dimitropoulos, Blackwell,
Walden, and Thompson (2006) observed a significant increase in the frequency of ritualistic
behaviors in children with Prader-Willi syndrome (PWS) then in children with a developmental
delay, but failed to find a significant difference in severity.
The prevalence of concomitant psychopathology within the intellectually disabled
population has been estimated to occur within 4-40% of the population (Deb et al., 2001; Dekker
& Koot, 2003; Rojahn, Borthwick-Duffy, & Jacobson, 1993). An increase in challenging
behaviors (e.g., aggressive and destructive behaviors) was positively correlated with the presence
of concomitant mental health symptoms in atypically developing children without an ASD
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(Matson et al., 2010). Despite the surge of research surrounding the ASD population, it is
important to note that the largest group of atypically developing infants and toddlers are those
with developmental and intellectual disabilities.
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ASD ASSESSMENT
A dearth in identified organic markers has led to an increased reliance upon observations
and the use of diagnostic measures for diagnosing ASDs (Baird et al., 2003; Matson & Neal,
2009). As knowledge of ASDs has increased, so has the availability of assessment measures and
screeners to identify autistic symptoms. The Modified Checklist for Autism in Toddlers (MCHAT) is a 23-item parent report checklist with answers being provided in a “yes/no” format
(Robins, Fein, Barton, & Green, 2001). It was developed specifically to screen toddlers (16-30
months) for the presence of ASDs (Robins et al., 2001). The Battelle Developmental Inventory,
Second Edition (BDI-2) is a comprehensive assessment battery of functional abilities across five
developmental domains: (a) personal-social, (b) adaptive, (c) motor, (d) communication, and (e)
cognitive (Alfonso, Rentz, & Suehee, 2010). The BDI-2 is often used to identify current
developmental level, assess for children “at-risk” for developmental delays, and identify
strengths and weaknesses of typically and atypically developing children (Newborg, 2005). The
screening portion of the BDI-2 requires 10 to 30 minutes for administration (Newborg, 2005).
Additional diagnostic measures for ASDs include but are not limited to the Autism
Diagnostic Interview-Revised (ADI-R; Lord, Rutter, & Le Couteur, 1994), Baby and Infant
Screen for Children with aUtIsm Traits (BISCUIT; Matson et al., 2007) the Childhood Autism
Rating Scale (CARS; Schopler, Reichler, & Renner, 1986). As discussed previously, multiple
behaviors have been identified as commonly occurring in toddlers with ASDs (Baranek, 1999;
Matson & Wilkins, 2008; Osterling & Dawson, 1994; Teitelbaum, Teitelbaum, Nye, Fryman, &
Maurer, 1998). Therefore clinicians often utilize direct observation measures to complement
informant based measures when diagnosing ASDs (Matson & Wilkens, 2009). The Autism
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Diagnostic Observation Schedule-Generic (ADOS-G) is an example of a standardized
observation measure (Lord et al., 2000).
However, researchers have noted the inability to utilize observation measures when
evaluating older children and when direct observation is not an option (Charman et al., 2003;
Matson & Wilkins, 2008). Different groups of researchers have examined home videos of ASD
children and compared them to videos of typically developing peers to identify behaviors unique
to ASD (Matson & Wilkins, 2008). The inability to standardize home video observation is an
identified flaw in such an approach, but it remains a valuable resource in the evaluation of older
children (Charman et al., 2003; Matson & Wilkins, 2008). The observation of poor visual
orientation and attention, object mouthing, unusual body posture, and aversion to social touch
were suggested by multiple researchers as unique in toddlers with ASD (Baranek, 1999;
Osterling & Dawson, 1994; Teitelbaum, Teitelbaum, Nye, Fryman, & Maurer, 1998).
Researchers also noted the common occurrence of certain “autistic behaviors” (e.g., covering
ears, stereotypies), social behavior, and joint attention as additional differences in toddlers with
ASD during home video analysis (Matson & Wilkins, 2008).
Assessment of Comorbid Psychopathology
The expansion of researchers investigating ASD and comorbid psychopathologies has led
to an increase in knowledge of the symptoms and features of ASDs. Tsai (2000) acknowledged
the existence of psychiatric symptoms as separate from ASD symptomology, a matter which was
previously the source of much debate. Howlin and Moss (2012) also demonstrated that if
symptoms of comorbid psychopathology are left untreated they continue to plague those with
ASD even as they mature into adulthood. Matson and Nebel-Schwalm (2007) suggested that
clinicians evaluating the presence of comorbid psychopathology within the infantile ASD
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population should assess for them multiple times due to the often cyclical presentation associated
with psychiatric disorders. This distinction made necessary the development of assessments to
properly detect the presence of concomitant psychopathologies in children. As agreement
concerning the presence of comorbid symptoms and the benefit of early intervention (e.g., EIBI)
has increased, researchers have explored the validity of assessing comorbidity in an infantile
populace (Dawson, 2008; Lovaas, Schreibman, & Koegel, 1974; Remington, et al., 2007; Smith,
Groen, & Wynn, 2004). However, until recently, an acknowledged gap in the research of
infantile ASD has been the lack of assessment measures analyzing psychopathology with ASD
norms (Matson et al., 2010).
The results gathered from early assessment of comorbid psychopathology help to identify
problems unique to an individual child which would allow for the customization of an
intervention strategy. Further, the compilation of research mapping the presence of comorbid
psychopathology in an infantile ASD population would aid in advancing understanding of the
presenting features and symptoms commonly observed in ASDs. The early recognition of
comorbid psychopathology may also aid in the identification of patterns or characteristics which
may help educate the individual’s family and caretakers by drawing their attention to the
complex nature of the disorders’ interactions they are being confronted with and affording them
the opportunity to educate themselves (Williams & Brayne, 2006). Increased knowledge would
also allow parents to explore other services available to them such as genetic counseling which
would include recurrence rates and inform reproductive decisions (McMahon, Baty, & Botkin,
2006; Simonoff, 1998).
Worley and Matson (2011) stressed the importance of caution and thorough assessment
to ensure the suspected psychopathological symptomology is not better accounted for by the
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ASD diagnosis. Assessment and interpretation is complicated due to the large variation in range
of functional abilities inherent to the hierarchical orientation of the ASD category. These factors
combined with the necessity of accurate diagnosis for efficacious intervention, make accurate
differential diagnosis crucial (Gillberg & Billstedt, 2000; Tsai, 1996).
Researchers have suggested that the manifestation and expression of comorbid
psychopathological symptoms within ASDs are unique and different from the presentation seen
in other disorders (Matson et al., 2007). While assessment measures such as the Behavioral
Assessment System for Children-Second Edition (BASC-2) and Child Behavior Checklist for ages
1.5-5 (CBCL) screen for the presence of comorbid psychopathology, these measures do not
include the norms necessary to account for the unique presentation witnessed in an ASD
population. The development of the BISCUIT-Part 2 has filled this gap (Matson, Wilkins,
Knight, Boisjoli, & Sharp, 2009).
Behavioral Assessment System for Children-Second Edition
The BASC-2 assessment battery is designed to assess psychopathology in toddlers as
young as 24 months of age and spanning up to adults 25 years of age (Reynolds & Kamphaus,
1992). The assessment battery contains a comprehensive set of forms whose inclusion is
dependent upon the assessed person’s age such as Teacher rating scale (TRS), Student
observation system (SOS), and a parent rating scale (PRS). With an average administration time
of 20 minutes, the Preschool TRS consists of 100 items. Item responses are rated based upon a
four-point scale reflecting the frequency of occurrence: N (never), S (sometimes), O (often), and
A (almost always; Reynolds & Kamphaus, 2004). The Preschool PRS utilizes a similar fourpoint response scale for the 134 items presented. Both scales assess for the presence of
internalizing and externalizing behavior problems and provide separate subscale scores such as
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anxiety, depression, and inattention (Reynolds & Kamphaus, 2004). This measure is limited by a
major factor relative to the interests of the present study; its normative age range, which begins
at two years of age, which would prevent it from being useful in early identification and
intervention approaches (Reynolds & Kamphaus, 2004).
Researchers are consistently placing emphasis on the early identification and intervention
in toddlers with ASD. The American Academy of Pediatrics (AAP) has placed an emphasis on
early identification by encouraging pediatricians to carry out ASD screeners at a child’s 18 and
24 month well-child checkups. Further supporting the role of early assessment, Matson and
Smith (2007) suggested participation in intervention programs for children diagnosed with an
ASD as early as 18 to 24 months of age. The unique symptoms observed in the ASD population
has led researchers to acknowledge the need for a measure that is designed to aid in the
identification and classification of symptoms that are indicative of either a concomitant
psychopathology, or being better described by the presence of an ASD (Matson, Boisjoli, &
Wilkins, 2007).
Child Behavior Checklist for ages 1.5-5
The need for the early assessment of psychopathology (i.e., 18 months of age) was
addressed by the development of a parent-report measure known as the CBCL (Achenbach &
Rescorla, 2000). The CBCL is a part of the Achenbach System of Empirically Based Assessment
(ASEBA), and is accompanied by the Caregiver–teacher rating form (C-TRF; Achenbach,
2009). The CBCL is a standardized measure that can be administered in 20 minutes. It assesses a
child’s psychopathology by examining both internalizing (e.g., anxiety, withdrawn, and
depressed), and externalizing (e.g., aggression, attention) behaviors as well as language
acquisition via the Language development survey (LDS). The CBCL and C-TRF forms are
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comprised of 99 items total, as well as additional descriptor sections allowing informants to
report any additional concerns or behaviors observed.
Separate factor analyses for both the CBCL and the C-TRF have identified a total of
seven factors for the CBCL (i.e., Emotionally Reactive, Anxious/Depressed, Aggressive
Behavior, Attention Problems, Somatic Complaints, Withdrawn, and Sleep problems) while the
latter excludes the “sleep problems syndrome” for a total of six factors (Liu, Cheng, & Leung,
2011). Also included in the scoring of the CBCL and C-TRF are five DSM-oriented scales:
Affective Problems, Anxiety Problems, Pervasive Developmental Problems, Attention
Deficit/Hyperactivity Problems, and Oppositional Defiant Problems (Achenbach & Rescorla,
2000). Statistical analysis of test-retest reliability identified an average correlation of .85 for the
CBCL and an average correlation of .81 for C-TRF (Rescorla, 2005). However, a limitation of
their paper was the failure to offer specialized norms on the CBCL for the ASD population.
Baby and Infant Screen for Children with aUtIsm Traits
To address both the need for early identification, and better account for the unique
presentation occurring in the ASD population an informant-based measure, the BISCUIT was
created (Matson et al., 2007). The BISCUIT assessment battery is composed of three parts and is
designed to assess infants and toddlers aged 17 to 37 months. Item selection was based upon the
methodology of scale development outlined by Crocker and Aligna (1986), and DeVellis (1991).
BISCUIT-Part 1 was created as a diagnostic tool for assessing infants and toddlers for either AD
or PDD-NOS. The BISCUIT-Part 2 is the primary focus of the present article, and measures
symptoms associated with concomitant mental health disorders (e.g., ADHD, obsessivecompulsive disorder, tic disorders, and specific phobias). Lastly, BISCUIT-Part 3 assesses for
the incidence of those challenging behaviors commonly observed in the ASD population.
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BISCUIT-Part 2 contains 65 items that are rated based upon the extent to which they
have been the source of recent impairment as follows: 0, “not a problem or impairment”; 1,
“mild problem or impairment”; 2, “severe problem or impairment”; or X, “does not apply or
don’t know” (Matson et al., 2008). Ratings of impairment/occurrence are accumulated and then
mapped onto five different subscales: ADHD, tic disorder, obsessive-compulsive disorder,
specific phobia, and eating/feeding difficulties. Matson, Boisjoli, Hess, and Wilkins (2011)
found the BISCUIT-Part 2 to have excellent internal consistency with alpha levels exceeding
.80, which is considered ideal (Clark & Watson, 1995).
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PURPOSE
Significant research has been published highlighting the increased occurrence of
comorbid psychopathological conditions in toddlers with ASDs when compared to both typically
and atypically developing peers (Barthélémy et al., 1992; Dawson, Matson, & Cherry, 1998;
Gadow, DeVincent, Pomeroy, & Azizian, 2004; Holden & Gitlesen, 2007; Horner, Carr, Strain,
Todd, & Reed, 2002; Matson et al., 2010; Matson & Nebel-Schwalm, 2007; Matson & Rivet,
2008; Paclawskyj, Matson, Bamburg, & Baglio 1997). Comorbid psychopathology in toddlers
with ASD complicates not only differential diagnosis and intervention approaches, but also
negatively impacts caregivers and the individual’s prognosis (Gray, Ansell, Baird, & Parr 2011;
Matson & Minshawi, 2007; Matson & Nebel-Schwalm, 2007). However, research has failed to
extend beyond prevalence rates to investigate the topography of comorbid symptoms in toddlers.
An increased knowledge concerning the topography of comorbid psychopathologies in toddlers
with ASDs is imperative to increase the knowledge of symptom manifestation, common
behavioral presentations within this population, and the trajectory and stability of symptoms.
This knowledge can inform multiple domains, including assessment, treatment, and etiology
(Matson et al., 1996; Matson & Bamburg, 1998; Matson, Hess, & Boisjoli, 2010).
The importance and success of early intervention approaches in the ASD population has
been recognized by many researchers (Peters-Scheffer, Didden, Korzilius, & Matson, 2012;
Peters-Scheffer, Didden, Korzilius, & Sturmey, 2011; Poustka, Rothermel, Banaschewski, &
Kamp-Becker, 2012; Reichow, 2012). Additionally, LoVullo and Matson (2009) identified the
need for highly individualized interventions when comorbid symptoms are present in toddlers
with ASD. However, these intervention techniques can only be beneficial when behavioral and
psychopathological factors are identified and targeted by intervention. It is also necessary that
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these interventions occur before the implementation of other interventions (e.g., educational) can
be expected to be fruitful. However, there is a scarcity of comorbid psychopathology research
available in toddlers, who have been identified as the benefactors of early interventions (Matson
et al., 2010).
Researchers have only just recently begun to extend the investigation of comorbid
symptoms to infants and toddlers. The current paper served as a means of further analysis of
developmental psychopathology. In order to assess for any comorbid psychopathology
symptoms the BISCUIT-Part 2 was administered to parents of infants and toddlers (17-37
months of age) with diagnoses of AD, PDD-NOS, or atypical development. The purpose of the
current study was primarily to investigate the expression of comorbid psychopathological
symptoms in an infant ASD population when compared to their atypically developing peers
without an ASD. Temporal influences on the expression of comorbid psychopathology
symptoms were also evaluated. The current research is important for enhancing the
understanding of the relationship between ASDs and comorbid psychopathology manifestation
during the early stages of development.
The stability of core symptoms in individuals with AD has been replicated in multiple
studies (Landa et al., 2007; Werner et al., 2005). Additionally, reliable early identification of
ASD has been linked to the presence of more severe symptoms found in toddlers with AD
(Matson & Horovitz, 2010). However, research investigating the manifestation of comorbid
psychopathology in infants is sparse. Investigation of developmental psychopathology in an
infantile and toddler populace with an ASD diagnosis is to the extent of this researcher’s
knowledge, very limited.
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It is hypothesized that comorbid psychopathology symptoms will be moderately stable in
all participants belonging to the AD and atypical development categories. A perfect replication
of scores from the first administration to the second cannot be anticipated due to the informantbased nature of the measure and testing familiarity associated with multiple administrations of
the same assessment. A significant amount of instability, however, is expected for the PDD-NOS
group due to the lack of specified criteria provided by the DSM-IV-TR for this diagnosis.
Furthermore, researchers have suggested concern surrounding the instability of the PDD-NOS
diagnosis itself in an infantile population (Stone et al., 1999, Worley et al., 2011). The
identification of symptom instability should not deter the assessment of individuals with a PDDNOS diagnosis. Rather, it should educate and prepare clinicians by identifying the need for
periodic reassessment to evaluate the intervention’s accuracy. Investigation of the temporal
influences are exploratory in nature and do not include a formal hypothesized outcome
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METHODS
Participants
Participants in the current study consisted of 315 infants and toddlers who had received
services provided by the state of Louisiana’s EarlySteps program. Louisiana’s Individuals with
Disabilities Education Act, Part C (2004) created EarlySteps, a program within Louisiana’s Early
Intervention System providing services to children and their families. In order to qualify for
services, children must have been identified as having a developmental delay or a medical
condition that places them as at risk for a developmental delay and fall within a specified age
range (i.e., birth to 36 months).
Following their participation in the EarlySteps program, individuals were separated into
one of three groups dependent upon their clinical diagnosis (i.e., AD, PDD-NOS, or atypical
development without an ASD). Diagnoses for an ASD were made in accordance with the criteria
outlined by the DSM-IV-TR by a licensed clinical psychologist. Diagnostic decisions were made
by reviewing the descriptors provided in the DSM-IV-TR for PDD-NOS (APA, 2000), the DSMIV-TR algorithm for AD, the individual’s scores on the BDI-2 (Newborg, 2005), and M-CHAT
scores (Robins et al., 2001). Participants were identified as atypically developing based upon a
failure to meet developmental milestones or the presence of genetic disorders (e.g., Down's
syndrome) or physical disabilities. The clinician assigning the diagnoses was a licensed
psychologist with more than 30 years of experience within the developmental disabilities field.
During the reviewing and subsequent diagnosis of cases, the clinician was blind to results from
the BISCUIT assessment. Initially, a total of 315 individuals were identified from a large dataset
who received two administrations of the BISCUIT-Part 2 and were within the identified age
range were considered for inclusion in the study. Scores for each of these individuals, diagnosis,
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and length of time between initial and follow-up administration were examined. Participants
were excluded from the study if adequate information was not included in the database (e.g.,
incomplete measures), if they did not retain their initial diagnosis, or if they received a follow-up
assessment in fewer than four months, or after 13 months. The final sample consisted of 205
toddlers (see Table 1 for demographic information). The sample was divided into three groups
based upon diagnosis: AD (n=35); PDD-NOS (n=32); or atypically developing (n=138).
Participants in each diagnostic category were also separated into two temporal groups for
further analysis, Time1 (AD n=20; PDD-NOS n=17; atypical development; n=72) or Time2 (AD
n=15; PDD-NOS n=15; or atypical development n=66). Additional information was also
gathered from the database (i.e., demographics [ethnicity and gender] and assessment
information [developmental quotient]). A preliminary Chi-square analysis was then used to
determine if significant differences in demographic variables (i.e., ethnicity or gender) and
assessment information between the diagnostic groups was evident. Demographic characteristics
are presented in Table 1.
Table 1
Participant Demographics
_____________________________________________________________________________
AD
PDD-NOS
Atypical
Total Sample
Age in months (SD)
23.51 (4.1)
23.09 (3.84)
23.24 (3.84)
23.26 (3.86)
Gender
Male
77.1%
78.1%
78.3%
78%
Female
22.9%
21.9%
21.7%
22%
Ethnicity
Caucasian
45.7%
43.8%
41.3%
48.3%
African-American
45.7%
43.8%
50.0%
42.4%
Hispanic
5.7%
0%
5.8%
4.9%
Other/Unspecified
2.9%
12.4%
2.9%
4.4%
Diagnostic percentage
17.1%
15.6%
67.3%
Developmental Quotient
72 (13.38)
80.56 (14.23)
86.77 (11.44)
83.67 (13.22)
Note: SD = Standard Deviation, AD = Autistic Disorder, PDD-NOS = Pervasive Developmental
Disorder – Not Otherwise Specified.
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Measure
Baby and Infant Screen for Children with aUtIsm Traits-Part 2 (BISCUIT-Part 2;
Matson et al., 2007). Researchers have suggested that the manifestation and expression of
comorbid psychopathological symptoms within ASDs are unique and different from the
presentation seen in other disorders (Matson et al., 2007). While assessment measures such as
the BASC-2 and CBCL screen for the presence of comorbid psychopathology, these measures are
not designed to account for the unique presentation witnessed in an ASD population. The
development of the BISCUIT-Part 2 to assess for comorbid psychopathologies has filled this gap
(Matson et al., 2009).
The BISCUIT-Part 2 is a singular component of a triad of informant based measures (i.e.,
BISCUIT-Parts 1-3) falling under the general battery developed to specifically screen for the
presence of ASD symptomology, comorbid psychopathology, and challenging behaviors in
infants and toddlers within the 17 to 37 month old age range (Matson et al., 2009). The
BISCUIT-Part 2 contains 65 items that respondents endorse on a 4-point Likert scale based upon
the extent that the item has been a recent problem as follows: 0, “not a problem or impairment,
not at all”; 1, “mild problem or impairment”; 2, “severe problem or impairment”; or X, “does not
apply or don’t know” (Matson et al., 2008). The BISCUIT-Part 2 is designed to assess for
symptoms associated with the following comorbid psychopathological disorders: ADHD, tic
disorder, obsessive-compulsive disorder, specific phobia, and eating/feeding difficulties (Matson
et al., 2009). An exploratory factor analysis identified five factors and led to the creation of the
following subscales: Tantrum/Conduct Behavior, Inattention/Impulsivity, Avoidance Behavior,
Anxiety/Repetitive Behavior, and Eat/Sleep Problems (Matson et al., 2011). When assessing
reliability, LoVullo and Matson (2012) found the BISCUIT-Part 2 to have excellent internal
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reliability with an alpha level of .96, which is indicated as ideal in the literature (Clark &
Watson, 1995). The cutoffs for the BISCUIT-Part 2 are different and based upon the toddlers
diagnosis (i.e., ASD or atypically developing) and are further separated by score into one of three
sections, No/Minimal Impairment, Moderate Impairment, and Severe Impairment.
See Table 2 for an indication of how the BISCUIT-Part 2 scores correspond with their
respective levels of impairment unique to each subscale in the ASD population. See Table 3 to
determine how the BISCUIT-Part 2 scores correspond with their respective levels of impairment
unique to each subscale in the atypically developing population.
Table 2
Severity levels in ASDs
_____________________________________________________________________________________
__________________________No/Minimal Impairment
Moderate Impairment
Severe Impairment
Tantrum/Conduct Behavior

0 to 16

17 to 24

25 and up

Inattention/Impulsivity

0 to 15

16 to 22

23 and up

Avoidance Behavior

0 to 6

7 to 10

11 and up

Anxiety/Repetitive Behavior

0 to 6

7 to 9

10 and up

Eat/Sleep Problems

0 to 3

4 to 5

6 and up

Table 3
Severity levels in atypical development without an ASD
_____________________________________________________________________________________
__________________________No/Minimal Impairment
Moderate Impairment
Severe Impairment
Tantrum/Conduct Behavior
0 to 6
7 to 10
11 and up
Inattention/Impulsivity

0 to 5

6 to 9

10 and up

Avoidance Behavior

0 to 1

1 to 2

3 and up

Anxiety/Repetitive Behavior

0 to 1

1 to 2

3 and up

Eat/Sleep Problems

0 to 1

2 to 3

4 and up

Procedure
Following referral to Louisiana’s EarlySteps program, the BISCUIT assessment battery
was administered to a parent/caregiver in addition to a comprehensive package of assessments to
gain relevant demographic and diagnostic information. The assessment battery was administered

46

to the same informant in the presence of the at-risk toddler twice with no less than three months,
but no more than one year separating the initial and follow-up administration. Assessments were
administered by evaluators employed by the EarlySteps program with a minimum of a bachelor’s
degree, but ranging up to a doctoral degree. The variance of educational attainment is further
complemented by assorted certifications and licenses representative of their respective
disciplines (e.g., psychology, education, social work, speech/language pathology, and early
childhood development). In addition to their educational background, each evaluator received
training in standardized assessment administration methods, and training specific to the measures
being administered. Approval of both the state of Louisiana’s Office for Citizens with
Developmental Disabilities and the Louisiana State University Institutional Review Board was
obtained prior to the utilization of the demographic and diagnostic information. Parental consent
was given at the time of assessment. The data obtained from these interviews was coded and
entered into an electronic database for analysis purposes.
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STATISTICAL ANALYSES
An a priori power analysis was carried out utilizing a statistical software package
identified as GPower*3 (Faul, Erdfelder, & Buchner, 2007) to determine the sensitivity of the
factorial multivariate analysis of variance (MANOVA) with a conservative harmonic mean. In
an effort to satisfy the standards provided by Cohen (1992) a desired power level of .80 was
selected along with an alpha (α) set at a significance level of .05 to determine the effect size
given the conservative harmonic mean sample size included. The parameters outlined above are
considered by Hinkle, Wiersma, and Jurs (2003) to be ideal in behavioral science research.
Given a conservative harmonic mean sample size (n = 45) an effect size of .20 would have an
achieved power of .80, an effect size of .25 would equate to an achieved power of .90, and an
effect size of .50 would have an achieved power of .99.
Prior to statistical analyses, both of the administrations of BISCUIT Part-2 were
reviewed to ensure that there were no missing item responses and that item values were valid
(i.e., 0, 1, or 2). Participants found to be missing more than 10% of responses for any subscale
for each administration of the BISCUIT Part-2 were excluded from the study. For the remaining
data set, Little's Missing Completely At Random test (MCAR; Little, 1988) was run to ensure
that the missing data was missing at random and not predictable from other variables or related
to the dependent variables or informant omission. The MCAR was not significant, indicating that
the items were missing completely at random (Tabachnick & Fidell, 2007; Van Ness, Murphy,
Araujo, Pisani, & Allore, 2007).
In order to estimate values for the missing items, the multiple imputation procedure was
used. The multiple imputation procedure involves multiple steps for estimating missing item
values (Tabachnick & Fidell, 2007). First, a logistic regression was carried out utilizing
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diagnostic category, time category, developmental quotient, and age as predictor variables.
Based upon these variables, the logistic regression creates an equation for estimating missing
item values for each diagnostic category (Tabachnick & Fidell, 2007). In order to identify the
distribution of variables with missing data, a random sample with replacement is then drawn
from the cases without missing variables. The identified variable distribution for each missing
item was then used to provide an estimate for the missing items in five random samples (with
replacement). The average imputed variable across all five samples for each missing item was
then included in a sixth dataset for analysis (Mehrotra, Li, Liu, & Lu, 2012; Rubin, 1987).
Statistical Solutions, Ltd. (1997) suggested that multiple imputations are advantageous for
within-subjects designs because the procedure retains the sampling variability.
Researchers have found the MANOVA to be robust to violations of non-normality, when
ten or more participants are included in each group (Seo, Kanda, & Fujikoshi, 1995). Tabachnick
and Fidell (2007) suggested that when sample sizes are unequal, a significant result from Box’s
M test for homogeneity of variance-covariance matrices should be followed by additional
analyses. For the current analysis, the ratio for any dependent variable for each diagnostic group
from smallest to largest variance does not exceed the 10:1 (Actual current Fmax = 3.71; 4:1) ratio
suggested by Tabachnick and Fidell (2007) to invalidate the use of a MANOVA. Further, the
discrepancy in sample size between diagnostic categories in the current sample is more
representative of the population distribution (Fmax = 4:1). All statistical analyses were run
utilizing the SPSS 21.0 software package.
Preliminary Statistics
A priori analyses were conducted to investigate potential differences between the three
diagnostic groups with respect to demographic variables including gender, ethnicity,
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developmental quotient, and age (see Table 1). Results of the chi-square analysis indicated that
there were no differences in gender (χ2 [2, N = 205] = .02, p = .99) or ethnicity (χ2 [6, N = 205]
= 7.94, p = .24) among the three groups. Although there was an observed difference in male to
female ratios in the ASD groups, the gender difference (approximately four times as common in
males) has been recognized by multiple researchers (Fombonne, 2005; Kanner, 1971). An
analysis of variance (ANOVA) was then conducted to test for any statistically significant
differences in age between diagnostic groups. Age was examined using Levene’s test, which
showed that homogeneity of variance was upheld (p = .90). Results of the ANOVA indicated no
significant age differences among the three diagnostic groups F (2, 201) = .11, p = .90.
An additional ANOVA was computed to determine if a statistically significant difference
existed between groups for the developmental quotient. Only a portion of the participants in the
current study had a developmental quotient score and could be included in this analysis (AD =
22, PDD-NOS = 25, Atypical = 108). The ANOVA revealed a significant difference among the
three groups for developmental quotient, F (2, 152) = 14.36, p < .01; however, due to the
unequal sample sizes, Hochberg’s GT2 corrected post hoc comparisons were computed (Field,
2009). Results of this analysis revealed that the difference resulted from significant differences
between the atypically developing group and the AD group (p < .01), there was not a significant
difference between the atypically developing and the PDD-NOS groups (p = .07) or the PDDNOS and AD groups (p = .06). Due to the observed differences in developmental quotient among
diagnostic categories this variable will not be entered as a covariate (Field, 2009).
A Kolmogorov-Smirnov test was then conducted for each factor (i.e., diagnostic category
and time) to test if the dataset was normally distributed. The result of this test of normality was
significant (p < .05) for Time and Diagnosis for each dependent variable. Histograms and Q-Q
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plots were also reviewed during tests of normality, and a positively skewed distribution was
observed. However, Field (2009) identified that when large samples are used, the KolmogorovSmirnov test can be significant even when scores vary slightly from a normal distribution. Field
(2009) additionally identified that due to the problem of small standard errors when a large
sample (n > 200) is used, no criterion for skewness and kurtosis should be applied.
In order to investigate the stability of comorbid psychopathological symptoms across
diagnostic groups, participants were first separated into their respective diagnostic categories
dependent upon diagnosis received following their participation in the EarlySteps program (i.e.,
AD, PDD-NOS, or atypically developing). The diagnosis being utilized was based upon the
methodology outlined in the contents of the participant section above. The difference between
each individual’s achieved score across both administrations of the BISCUIT-Part 2 for each of
the five factors was then computed. An absolute difference score between initial and follow-up
assessment was then computed for each factor and represents the amount of change for each
factor among the three diagnostic groups. Due to the desire to measure any change in symptoms,
the absolute difference score ignored directionality (i.e., increased item endorsement, or
decreased item endorsement). Utilizing this classification system, the stability of symptom
expression was then examined based upon observed changes in item endorsement between two
assessments.
The time lapse between successive administrations was also examined. In order to
thoroughly investigate the influence of temporal factors on symptom stability, a two-part
classification system was created. Participants were segregated into two groups dependent upon
the time span separating their initial and follow-up evaluation. Participants with a span of 4 to 8
months between their initial and follow-up assessments composed one group (i.e., Time1), while
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the second group consisted of participants whose follow-up assessments were conducted 9 to 13
months (i.e., Time2) after initial evaluation. The ranges expressed here are centered upon the
EarlySteps programs attempt to reassess individuals at six month intervals (e.g., 6 months, and
12 months).
Study
A 3 X 2 factorial between-subjects MANOVA was computed to assess whether there are
significant changes in item endorsement based upon diagnosis (i.e., AD, PDD-NOS, and atypical
development) and/or time (i.e., time spans between the initial and follow up evaluation) across
two administrations of the BISCUIT-Part 2. The current study contained two independent
variables. The identified between-subjects factors were, diagnosis (i.e., AD, PDD-NOS, and
atypical development), and the length of time between the assessments (i.e., 4 to 8 months or 9 to
13 months). The dependent variables between-subjects factor were the absolute difference’s
derived from each participant’s respective BISCUIT-Part 2 scores across both administrations
for each subscale. Descriptive statistics were run in order to identify the respective mean for each
temporal group. A series of univariate ANOVAs were computed for each dependent variable
with Bonferroni corrections to control the inflation of Type I error. Following a significant main
effect for diagnosis, pairwise comparisons were computed between each respective diagnostic
category which included all individuals regardless of the time factor. Due to the observed
differences in sample sizes, Field (2009) recommends that a Gabriel’s procedure will be too
liberal and instead both Hochberg’s GT2 and Games-Howell procedures be selected for post hoc
analysis. Finally, the significant MANOVA was followed with a discriminant functional analysis
for the diagnostic categories to analyze the underlying relationships between dependent
variables.
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RESULTS
Initially, descriptive statistics were computed to look at the mean and standard deviation
for the absolute difference for each of the five factors of the BISCUIT-Part 2 based upon
diagnostic category (Table 4).
Table 4
Means and standard deviations of the absolute difference factor scores on the BISCUIT Part-2
for all three levels of the independent variables
AD
PDD-NOS
Atypical
M (SD)
M (SD)
M (SD)
n = 35
n = 32
n = 138
Factor 1
Sleep
2.11 (1.43)
1.00 (1.24)
0.84 (1.10)
Factor II
ADHD
5.63 (4.94)
3.22 (3.53)
2.3 (2.88)
Factor III
Avoidant
2.51 (2.65)
1.78 (2.56)
0.78 (1.40)
Factor IV
Anxiety
3.80 (2.95)
1.84 (2.30)
1.18 (1.64)
Factor V
Tantrum
6.60 (6.07)
4.78 (5.10)
2.62 (3.11)
Note: SD = Standard Deviation, AD = Autistic Disorder, PDD-NOS = Pervasive Developmental
Disorder – Not Otherwise Specified. The absolute difference between the initial and follow-up
assessment was used to calculate the above values.
A MANOVA was performed on two independent variables: diagnostic group (i.e., AD,
PDD-NOS, and Atypical) and time lapse (i.e., Time1 and Time2). There were five dependent
variables based upon the absolute difference between the two subscale totals of the five factors
of the BISCUIT-Part 2. A significant Box’s test suggested that homogeneity of variancecovariance was violated. However, due to the vulnerability of having a significant Box’s test
when there is a discrepancy in sample size is present, additional analyses were conducted,
revealing that the assumption was tenable (Fmax = 4:1). Field (2009) suggested the use of
Pillai’s trace for interpreting the results of a MANOVA when group sizes are different and
groups differ along more than one dimension. Using Pillai’s trace, a significant main effect of
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diagnosis on the stability of comorbid symptoms was observed, V = .29, F (10, 392) = 6.54, p <
.01, partial η2 = .14. Additionally, a significant main effect of Time was also observed, V = .08,
F (5, 195) = 3.33, p < .05, partial η2 = .08. The interaction between diagnostic category and the
time between original and follow-up assessment was not found to be significant, V = .08, F (10,
392) = 1.63, p = .1, partial η2 = .04. The observed interaction between diagnosis and time was
not significant. The results of the significant MANOVA were indicative of differences among
the diagnostic categories. The significant main effect for Time indicated that three factors of the
BISCUIT-Part 2 were significantly different when assessed at a later time period (i.e., Time2;
Table 5). Specifically, significant differences between Time1 and Time2 were observed for the
following factors: ADHD F (1, 203) = 4.61, p < .05, partial η2 = .02, Avoidant F (1, 203) = 6.1,
p < .01, partial η2 = .03, and Tantrum F (1, 203) = 6.19, p < .01, partial η2 = .03.
Table 5
Means and standard deviations of factor scores on the BISCUIT Part-2 based upon time between
initial and follow-up assessment
Time1
Time2
M (SD)
M (SD)
n = 109
n = 96
Factor 1
Sleep
0.10 (1.75)
-0.26 (1.56)
Factor II
ADHD
-0.22 (4.17)
-2.15 (4.81)
Factor III
Avoidant
-0.06 (1.88)
-0.64 (2.71)
Factor IV
Anxiety
-0.03 (2.64)
-0.52 (2.99)
Factor V
Tantrum
0.01 (4.88)
-1.70 (6.26)
Note: SD = Standard Deviation. The absolute difference between the initial and follow-up
assessment was used to calculate the above values.
The significant main effect for diagnosis observed in the MANOVA was followed up
with ANOVAs for each of the five factors of the BISCUIT Part-2. The factor score for each
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ANOVA will be discussed separately. Factor I, Sleep, did not violate any of the assumptions of
the ANOVA and a significant main effect of diagnosis was observed F (2,202) =16.20, p < .01,
partial η2 = .13. Each of the remaining four factors did violate the homogeneity of variance
assumption for an ANOVA, and therefore the more robust Welch’s test is reported. Factor II,
ADHD, indicated a main effect of diagnosis Fw (2, 52.84) = 7.69, p < .01, partial η2 = .13. A
Welch’s test for Factor III, Avoidant, indicated a main effect of diagnosis Fw (2, 49) = 8.69, p <
.01, partial η2 = .13. A Welch’s test Factor IV, Anxiety, indicated a main effect of diagnosis Fw
(2, 51.15) = 13.24, p < .01, partial η2 = .20. Finally, a Welch’s test for Factor V, Tantrum, also
indicated a main effect of diagnosis Fw (2, 49.50) = 9.04, p < .01, partial η2 = .14.
Due to the difference in sample sizes and difference in population variances (Fmax =
4:1), the Games-Howell procedure was used to control for the inflation of Type I errors when
running multiple comparisons. The Games-Howell procedure has been identified as the most
powerful and accurate when sample sizes are not equal (Field, 2009). The post hoc comparisons
for each of the five factors of the BISCUIT Part-2 were examined separately. Post hoc
comparisons using the Games-Howell procedure indicated that the mean difference between the
AD and Atypical groups were significant for each factor (p < .05; Table 6). Additionally, the
average difference between ASD groups was significant for two factors, Sleep and Anxiety (p <
.05; Table 6). No significant differences in developmental psychopathology were observed
between the PDD-NOS and Atypical groups (Table 6).
The MANOVA was also followed by descriptive statistics to analyze the observed trend
of change in comorbid symptom expression for each diagnostic category across administrations
and in what direction the change occurred (Table 7).
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Table 6
Mean difference between diagnostic groups following Post hoc comparisons using the GamesHowell procedure
AD/PDD-NOS
PDD-NOS/Atypical
AD/Atypical
M (SD)
M (SD)
M (SD)
n = 35
n = 32
n = 138
Factor I
Sleep
1.11**
0.16
1.27**
Factor II
ADHD
2.41
0.91
3.32**
Factor III
Avoidant
0.73
1.00
1.73**
Factor IV
Anxiety
1.96*
0.66
2.62**
Factor V
Tantrum
1.82
2.17
3.98*
Note: SD = Standard Deviation, AD = Autistic Disorder, PDD-NOS = Pervasive Developmental Disorder
– Not Otherwise Specified. The absolute difference between the initial and follow-up assessment was
used to calculate the above values. *significant at the .05 level, **significant at the .01

Table 7
Mean difference for factor scores on the BISCUIT Part-2 for all three levels of the independent
variable
AD
PDD-NOS
Atypical
M (SD)
M (SD)
M (SD)
n = 35
n = 32
n = 138
Factor I
Sleep
0.57 (2.51)
-0.25 (1.58)
-0.19 (1.38)
Factor II
ADHD
-0.94 (7.49)
-0.78 (4.74)
-1.25 (3.47)
Factor III
Avoidant
-0.46 (3.65)
-0.97 (2.98)
-0.14 (1.60)
Factor IV
Anxiety
-0.09 (4.85)
-0.47 (2.93)
-0.25 (2.00)
Factor V
Tantrum
-0.77 (9.00)
-1.28 (6.92)
-0.68 (4.00)
Note: SD = Standard Deviation, AD = Autistic Disorder, PDD-NOS = Pervasive Developmental Disorder
– Not Otherwise Specified.

Additional post hoc analyses included a discriminant analysis to investigate the
relationship between the dependent variables and how the dependent variables discriminate the
diagnostic categories in the current study (Field, 2009). In the current model discriminant
analysis revealed two discriminant functions. The first function explained 87.7% of the variance
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(canonical R2 = .23), whereas the second function explained 12.3% of the variance (canonical
R2 = .04). In combination these discriminant functions significantly differentiated the diagnostic
groups, Λ = .76, χ2 (10) = 61.50, p < .01. However, removing the first function revealed that the
second function did not significantly differentiate the diagnostic groups, Λ = .96, χ2 (4) = 8.34, p
= .08. The correlations between outcomes and the identified discriminant functions revealed that
Anxiety loaded disproportionately higher on the first function and not the second (r = .87 and r =
-.10 respectively). Similar patterns were observed for the factors Sleep (r = .72 and r = -.33) and
ADHD (r = .66 and r = -.04). Correlations between the first and second discriminate function
remained disproportionate but positive for the remaining two dependent variables, Tantrum (r =
.67 and r = .43) and Avoidant (r = .64 and r = .46). The discriminant function plot (Figure 1.)
showed that the first function discriminated the AD and PDD-NOS groups from the Atypical
group, while the second function differentiated the AD and Atypical groups from the PDD-NOS
group.

Figure 1 Discriminant function plot. This figure depicts the two functions underlying the
relationships between the dependent and independent variables.
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DISCUSSION
Treating an ASD during infancy has been proven beneficial (Ben-Itzchak et al., 2008;
Eaves & Ho, 2004; Matson & Smith, 2008; McEachin et al., 1993). Additionally, core symptom
stability in individuals with AD has been replicated in multiple studies (Landa et al., 2007;
Werner et al., 2005). However, researchers have not yet expanded this research to include
symptoms of developmental psychopathology. Researchers have repeatedly reported the higher
occurrence of comorbid symptoms in the ASD population when compared to their typically and
atypically developing peers (Gillberg & Billstedt, 2000; Kim, Szatmari, Bryson, Streiner, &
Wilson, 2000; Matson, Hess, & Boisjoli, 2010; Park et al., 2012; Schreck et al., 2004). Despite
the observed increase in frequency of occurrence in individuals with an ASD, this topic has
received minimal empirical research to date (Matson et al., 2010; Matson & Nebel-Schwalm,
2007). Even less frequent have been investigations of the expression of comorbid symptoms in
an infantile ASD populace (Angold & Egger, 2004; Matson et al., 2010). The current study
sought to explore symptoms of developmental psychopathology in an infantile ASD population
based upon the BISCUIT-Part 2. Results from the current study indicated that not only are
symptoms of developmental psychopathology less stable in infants with ASD, but also that the
time between assessments is a significant factor influencing stability.
The diagnostic group had more comorbid symptoms than controls. This finding indicates
that not only are comorbid symptoms more prevalent in infants with ASD (Gillberg & Billstedt,
2000; Kim et al., 2000; Park et al., 2012; Schreck et al., 2004), but that the prevalence of these
symptoms increase with age. The current findings are commensurate with researchers who have
also reported that juveniles and adults with ASDs exhibit significantly increased rates of
comorbid conduct behaviors (i.e., tantrums and aggression) and ADHD when compared to
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typically developing peers (Horner, Carr, Strain, Todd, & Reed, 2002; Matson et al., 2010;
Matson & Rivet, 2008). Contrary to these results, some researchers have not reported significant
differences in comorbidity when comparing ASD and non-ASD populations. Utilizing the
Autism Spectrum Quotient (AQ; Baron-Cohen, Wheelwright, Skinner, Martin, & Clubley, 2001)
to identify participants with ASD, Ketelaars and colleagues (2008) did not observe significant
differences in the expression of comorbid symptoms when compared to non-ASD peers.
However, The AQ was not developed as a diagnostic measure, and was originally developed to
screen for autistic symptoms in individuals with normal intellectual functioning (Baron-Cohen,
Wheelwright, Skinner, Martin, & Clubley, 2001).
A significant main effect for time in the current study revealed that the length of time
between follow up assessments had a medium effect on the expression of comorbid symptoms.
Post hoc analyses indicated that time had a small, yet significant, effect on the stability of three
factors (i.e., ADHD, Avoidant, and Tantrum behaviors), but not the remaining two factors (i.e.,
Sleep and Anxiety). Descriptive statistics revealed an increase in behavior exhibition for each
factor for the Time2 group. The same pattern was not observed in individuals in the Time1
group. Contrarily, item endorsements for the factors Sleep and Tantrum indicate that there was a
decrease in these behaviors when follow-up assessment occurred within six to eight months.
The significant effect of time on developmental psychopathology and the observed
increase for each of the five factors assessed suggests that the exhibition of comorbid symptoms
is not static and may increase with time. Symptoms of comorbid psychopathology increased
across time regardless of primary diagnoses. While two factors (i.e., Sleep and Tantrum) actually
decreased in Time1, all five factors of the BISCUIT-Part 2 increased in prevalence when
assessed between nine and twelve months. Statistically significant differences were observed for
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three factors in the Time2 group, ADHD, Anxiety, and Tantrum (Table 5). While these factors
were significantly different, only a small time effect was observed.
Contrary to my hypothesis, the expression of comorbid symptoms in the PDD-NOS
group was not significantly different than that seen in the Atypical group for any factor on the
BISCUIT-Part 2. Individual analyses of the absolute differences between item responses for each
factor indicated that although symptom expression for infants with PDD-NOS was not
significantly different, it did reveal an overall increase in symptom expression (Table 4). A large
effect of diagnosis on developmental psychopathology was observed for each of the five
BISCUIT-Part 2 factors. These findings are commensurate with previous research by Matson
and colleagues (2010) who found a significantly higher prevalence of comorbid symptoms in
ASD toddlers when compared to controls. Multiple comparisons for each of the five factors were
conducted following significant ANOVAs. Post hoc analyses revealed that symptom stability for
the factors significantly differed amongst the ASD categories. Specifically, item responses for
the AD group when compared to the PDD-NOS group significantly differed for two factors (i.e.,
Anxiety and Sleep). Researchers have previously observed significantly higher endorsement of
anxiety symptoms in AD populations when compared to a PDD-NOS group and control group
using the BISCUIT-Part 2 (Matson et al., 2010). Similarly, researchers have suggested that AD
populations exhibit fears and phobias at higher rates than both typical and atypically developing
peers (Evans et al., 2005; Matson & Love, 1990). Increased rates of anxiety and repetitive
behaviors (i.e., tics), have also been observed in ASD populations (Attwood, 1998; Ringman &
Jankovic, 2000). Post hoc analysis of item responses revealed a decrease in the expression of
comorbid sleep symptoms for the AD group (Table 7).
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Sleep was the only factor in the current analysis for which the observed difference
between the initial and follow up assessment was positive. However, as indicated in Table 7, the
average difference in item responses for the Anxiety factor within the AD group was nearly
positive. The difference in expression of anxiety and sleep symptoms among the AD and PDDNOS groups cannot be fully understood with this initial analysis. In the future researchers should
explore the differences amongst these factors in depth. The remaining factors (i.e., Tantrum,
Avoidant, and ADHD), did not significantly differ among ASD diagnoses. Ignoring
directionality, analysis of item responses for each of the five factors of the BISCUIT-Part 2
across two administrations were significantly less stable for the AD group when compared to the
atypical group.
The observed findings suggest that the expression of comorbid symptoms by infants with
AD is not static and can change across time when compared to atypically developing peers. The
instability in the AD group identifies the need for reassessment/evaluation across time for this
group in particular when developing and implementing intervention programs. Regardless of
diagnosis, an overall increase in developmental psychopathology was observed for each factor of
the BISCUIT-Part 2 with the exception of Sleep for the AD group. Aside from this specific
factor, the overall trend observed in the data indicates that the assessment and continuous
monitoring of developmental psychopathology is important regardless of primary diagnosis.
Research regarding the manifestation of comorbid symptoms in infants with ASD is paramount
in developing and implementing proper interventions (Kim et al., 2000).
The observed outcome of the discriminant analysis indicates that one underlying
dimension best captures group separation. As exemplified by a discriminant function plot (Figure
1), the presence of an ASD is likely to be the underlying dimension producing significant
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differences among diagnostic groups. This observation directly supports the results of multiple
post hoc comparisons which revealed significant differences between the AD and Atypical
groups for each of the five factors and insignificant differences between the ASD groups for
three of the five factors. The first variate has a strong positive relationship with each of the five
DV’s, but most notably with Anxiety and Sleep. These two factors were also the only two factors
that significantly distinguished the AD group from the PDD-NOS group during post-hoc
multiple comparisons. In direct contrast, the second variate affects Anxiety, Sleep, and ADHD
differently from Tantrums and Avoidant symptoms. When the canonical variate correlations of
DV’s are high for one variate and low for another, the high correlations contribute the most to
group separation (Bargman, 1970). This information suggests that the first variate affects each of
the BISCUIT-Part 2 subscales in the same manner, whereas the second variate differentiates
groups on some dimension that affects Anxiety, Sleep, and ADHD differently. When the two
discriminate functions were compared, only the first function significantly discriminated
diagnostic group membership.
In contrast, with the stability of the core ASD symptoms observed in children with AD by
multiple researchers (Landa et al., 2007; Werner et al., 2005), the current research suggests that
symptoms of comorbid psychopathology are not stable, and actually increase across time
regardless of diagnosis. Previous researchers have identified the negative impact of comorbid
symptoms on individuals with ASDs (Gray, Ansell, Baird, & Parr 2011; Matson & Minshawi,
2007; Matson & Nebel-Schwalm, 2007). The current findings highlight the importance of the
continuous monitoring of developmental psychopathology and the need for the development and
implementation of specific interventions for infants and toddlers.
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While behavioral interventions (i.e., EIBI) have been shown to be effective for children
with an ASD, the presence of other comorbid developmental psychopathology problems requires
the development of highly individualized interventions (LoVullo & Matson, 2009). Additional
interventions, such as the use of psychotropic medication in combination with EIBI, may be
necessary for children with ASD when comorbid disorders are present (LoVullo & Matson,
2009; Self, Hale, & Crumrine, 2010). Research surrounding the manifestation of comorbid
symptoms in an infantile ASD population is critical. The presence of comorbid symptoms
influence diagnostic formulation and the development of treatment plans, which may negatively
impact not only the individual, but also parental stress (Gray, Ansell, Baird, & Parr 2011;
Matson & Minshawi, 2007; Matson & Nebel-Schwalm, 2007). While it is not efficacious to
withhold treatment from those that may benefit from it, it is equally important to understand how
symptoms, especially comorbid symptoms manifest independent of treatment in order for
researchers to reliably determine the efficacy of additional interventions. Outcomes of the
present study suggest that the presence of comorbid symptoms do not simply dissipate as
children age. Instead, these symptoms become increasingly prevalent and severe. Comparisons
between the AD, PDD-NOS, and Atypical groups indicated that this increase in or worsening of
comorbid symptomatology was significantly greater in those infants with AD. These findings
suggest that intervention for comorbid symptoms in an infantile ASD population is a necessary
venture, especially infants with AD. While differences between both time groups analyzed where
only significant for the Time2, an overall positive trend in comorbid symptom expression was
observed for both groups (Table 5). The findings of the current study also highlight the need for
consideration of the time between initial and follow-up assessments. They suggest that the
assessment of comorbid symptoms may need to occur at a later date. Dominick and colleagues
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(2006) reported that half of their children with autism in their study expressed severe tantrums
after the age of 3. The current findings should be considered in light of the current legislative
approaches to early autism intervention. The current EarlySteps program only pertains to
individuals up to 36 months. If participants are identified within the 24-36 month age range (73
of the participants in the current study) they would likely age out of the program before their
presentation of comorbid symptoms was fully assessed and certainly before adequate
interventions for comorbid symptoms were developed and introduced. Additionally, these factors
likely interfere with the administration of other interventions (I.e., OT, PT), especially if
challenging behaviors are present.
The results of this study should be confirmed by research which monitors any change in
developmental psychopathology over the course of the implementation of highly individualized
intervention programs. Such research may help to inform the development of future treatment
approaches. The current findings may also inform the development of diagnostic and assessment
measures to assist in the early detection and treatment of both ASDs and comorbid
psychopathologies in toddlers. The results of the current research offer new information
concerning the manifestation of psychopathology symptoms in toddlers with an ASD. Such
knowledge contributes to the ongoing efforts to better understand the features and symptoms of
ASDs, provide valuable information for the assessment of psychopathology in toddlerhood, and
lead to the development of more efficacious and streamlined treatment approaches for early
intervention in ASDs. Enhancing our understanding and ability to identify comorbid symptoms
in infants with ASD remains important. Matson and colleagues (2010) suggested that the course
of symptoms associated with conduct problems and behavioral challenges may be altered with
early identification and intervention implementation. In an effort to include as many participants
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as possible, no effort was made to control group sample size. Future research should utilize equal
sample sizes and include a typically developing control group. This direct comparison may
highlight the benefit of interventions for comorbid symptomology in both the ASD and Atypical
groups. Researchers should continue to identify and include additional factors that may influence
the expression of comorbid symptoms or predispose children with ASD to developing comorbid
symptoms.
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